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Chapter One: Systematic Review 
 
Experiences of Non-Invasive Ventilation for Patients with Motor Neurone 
Disease and Their Carers: A Qualitative Systematic Review 
 
 
Prepared in accordance with the author requirements for the International Journal of 








This systematic review aimed to synthesise qualitative literature exploring experiences of being 
offered non-invasive ventilation (NIV) as part of treatment in Motor Neurone Disease (MND), from 
the perspectives of patients and carers.  
Methods 
A systematic search was conducted to identify qualitative studies that explored experiences of MND 
patients and carers who have been offered and/or use NIV. A quality appraisal tool was used to 
assess papers prior to synthesis. Meta-ethnography was conducted on ten research studies. 
Results  
Five superordinate themes were identified; 1) Attitudes and coping styles; 2) Balancing discomfort 
with benefits; 3) Impact of continuing deterioration; 4) Fear and uncertainty; 5) Challenges of 
professional support. 
Conclusions  
The synthesis identified attitudes and coping strategies that patients use to maintain quality of life, 
autonomy, and control, and how these can change over time. Uncertainty impacts on both patients 
and carers, who experience a loss of autonomy which complicates decision making around NIV. 
Fears played a role in rejecting or withdrawing from interventions, particularly a fear of dependence. 
Loss of autonomy can be experienced during interactions with professionals. Recommendations for 
clinical practice are discussed, such as improving individualised information and support; increasing 
autonomy; and improving person centred care. 





Motor Neurone Disease (MND) covers a group of neurodegenerative diseases which involve the 
progressive deterioration of upper and lower motor neurones. This results in a loss of voluntary 
muscle movement, and subsequently a decline in movement, speech, breathing and swallowing 
(Young et al., 2019). Changes can also include frontotemporal dysfunction, including changes to 
cognition and behaviour (Strong et al., 2017). Most people with MND die within 3-5 years after 
symptom onset, often from health complications related to bulbar dysfunction or respiratory failure 
(Burkhardt et al., 2017). Although some treatments can prolong survival, their main aim is to 
improve symptom management and quality of life where possible. Respiratory weakness can result 
in difficulties which impact on quality of life, such as a lack of concentration, poor sleep, fatigue, and 
shortness of breath (Lyall et al., 2001).  
Non-invasive ventilation (NIV) is an intervention to support breathing which can help control 
respiratory symptoms. . NIV is a type of assisted ventilation, involving a small machine which 
provides increased air flow to the lung, usually through a mask which is held on by straps. This type 
of ventilation is seen as non-invasive in relation to interventions such as a tracheostomy, otherwise 
known as invasive ventilation. This also provides increased air flow, but involves undergoing surgery 
to allow a tracheostomy tube to be inserted into the windpipe. NIV can allow people to have this 
treatment at home, but this usually requires support from family members or professional carers 
(O’Neill et al., 2012). 
NIV has been shown to improve quality of life (Walsh & Murphy, 2020), sleep quality (Boentert et al., 
2015) and survival in MND (Burkhardt et al., 2017). According to the NICE guidelines on the 
assessment and management on MND (2016; updated 2019), all patients with respiratory muscle 
decline should be offered NIV. The use of NIV has increased as evidence of its benefits have 
increased and factors such as rapid disease progression are no longer considered as barriers for the 
intervention (O’Neill et al., 2012). Family caregivers who had relatives with MND who were receiving 
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NIV were found to be less anxious than those whose relatives were not receiving this treatment 
(Cousins et al., 2013).  
Despite these advantages, not everyone who is offered NIV will accept it. Despite its 
recommendation in treatment guidelines, utilisation rates of NIV are low (Spittel et al., 2020). 
Transitions such as adjusting to life-sustaining treatments (e.g., home mechanical ventilation or 
gastrostomy) and using new communication methods can impact on the quality of life of people 
with motor neurone disease and their caregivers (e.g., Caron & Light, 2015). Relationships between 
the patient and caregiver can also be negatively affected (Cipolletta & Amicucci, 2015). These 
transitions can seem constant, with individuals and families facing complex decisions, often planned 
far in advance while dealing with day-to-day uncertainty.  
A mixed methods study examining factors influencing acceptance of NIV and gastronomy highlighted 
the complexity of this decision-making process (Martin et al., 2014). Psychological factors such as 
beliefs and perceptions around MND and interventions such as NIV and gastrostomy, and attitudes 
towards interventions and disease management, were likely to influence decision making. 
Demographic factors, illness variables and executive dysfunction also had an impact. Having family 
caregivers who are able to cope with the transition to NIV has been highlighted as an important 
factor for enabling MND patients to sustain NIV treatment (Cousins et al., 2013). This may be of 
increased importance due to lack of support from services. MacLaren et al. (2019) suggested that 
people do not receive adequate care resources to support the provision of ventilation. 
Research on the experiences of using home mechanical ventilation across conditions indicates that 
patients have the contradictory experience of increased freedom and quality of life alongside 
increased dependency and uncertainty (Ørtenblad et al., 2019). Some qualitative research focusing 
on the experiences of non-invasive ventilation within MND has identified similar themes as well as 
focusing on how these experiences can change over time (Ando et al., 2014a) and how this can 
influence decision making (Ando et al., 2014b). 
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A recent study reviewed quantitative and qualitative data on the optimal provision of NIV (Baxter et 
al., 2019). This provides a comprehensive overview of available research and provided 
recommendations for clinical practice. However, this review took a mixed methods approach to 
integrate this data. It would be worthwhile to conduct a quality appraisal of additional available 
qualitative evidence which may have been out with the scope of the previous review and to carry 
out a meta-synthesis. Studies which have looked at the experiences of MND patients and carers of 
being offered NIV have produced rich, descriptive data. Synthesising these findings together as part 
of a meta-synthesis will provide an in-depth insight into these experiences and complement 
quantitative data reported elsewhere. Improving our understanding of how people with MND 
perceive being offered and making choices around NIV, and how they experience any benefits and 
disadvantages of using NIV may allow healthcare professionals to improve how they support 
patients and carers in making decisions regarding use of NIV and how they support patients in 
longer-term use of NIV. 
While there have been changes in clinical practice and a wider recognition of the impact of NIV on 
survival and quality of life, it is important that patients’ experiences of care and treatment are 
presented alongside both evidence for an intervention and the views of healthcare professionals. 
Increased understanding of perceived obstacles to NIV and benefits of NIV will help to increase 
insight into positive experiences of NIV other than survival. 
Purpose of this review 
The review aimed to synthesise the available evidence exploring the experiences of being offered 
NIV as part of treatment in MND, from the perspectives of both patients and carers. Study quality 
was appraised and meta-ethnography was used to generate new insights into patients and carer 





This systematic review followed the guidance in the Preferred Reporting Items for Systematic 
Reviews and Meta-Analyses (PRISMA). A protocol for the review was preregistered with PROSPERO 
International Prospective Register of Systematic Reviews (CRD42021243672).  
Search Strategy 
The following search was carried out in March 2021. Search terms and database selection were 
developed in consultation with a subject librarian. Four electronic databases were searched - 
CINAHL, EMBASE, Medline and PsycINFO. References and citations were searched within selected 
studies.  
Search Terms 
Identified databases were searched using key terms for the three key components: ‘motor neurone 
disease’, ‘non-invasive ventilation’ and ‘qualitative research’. Key words and indexing terms 
following search terms (MeSH and thesaurus terms) were used as subject headings and title or 
abstract terms, which varied between databases. A validated qualitative filter was used in searches 
where possible and adapted for different databases. Within each component the Boolean operator 
OR was used to group terms and components were combined with AND (see Appendix 1.1 for a 
detailed search strategy). 
Eligibility Criteria 
Studies were included if; i) participants were patients with a diagnosis of MND, or carers of patients 
with MND; ii) the study was a qualitative or mixed methods design; iii) the focus was on the 
experience of non-invasive ventilation; iv) the paper was published in a peer reviewed journal; v) the 
study was in English. 
Studies were excluded if; i) participants were all health care professionals; ii) the focus of the paper 
was not about the experience of non-invasive ventilation or focused solely on invasive ventilation; 
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iii) participants had a diagnosis other than MND; iv) the study was a quantitative design; v) the study 
was a review or conference abstract.  
Data Selection 
The search yielded 159 results, of which 44 were duplicates (See Figure 1). Electronic searches were 
documented for transparency (see Appendix 1.2). Titles and abstracts were screened by the primary 
researcher utilising the inclusion and exclusion criteria, prior to screening the remaining full text 
papers. A peer reviewer (Trainee Clinical Psychologist) screened 50% of the titles and abstracts and 
there were no disparities between reviewers. 90 records were excluded at this stage. Hand searches 
of references, grey literature and citation searches did not identify any additional eligible papers. 
The full text of 24 papers were reviewed, 10 of which met inclusion criteria for the synthesis.  
Two papers (Ando et al., 2014a and Ando et al., 2014b) were part of the same longitudinal study of 
NIV in MND. The first paper examined experiences of NIV treatment after 12-14 months of use, 
whereas the second interviewed participants who declined or withdrew from NIV and were 
therefore not included in the first study. Another three papers (Baxter et al., 2013a; Baxter et al., 
2013b; Baxter et al., 2013c) were part of a longitudinal study examining experiences of NIV at 
different time points and from different perspectives and appears to include the same participants. 
The question of whether to group these two sets of papers together was considered, but it was 
decided to include all studies separately as they reported on different aspects of experiences.
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Figure 1.  





















Records identified through databases 
  CINAHL                    n= 20 
  EMBASE                  n= 106 
  Medline                  n= 25 
  PsycINFO                n= 8 











Additional records identified 
through other sources 
(n = 0) 
Reference searches 
Screened n= 2                       Accepted n=0 
Citation searches 
Screened n= 3                       Accepted n=0 
 
Hand searches 
Screened n=1                      Accepted n=0 
Total:                                                      n=0    
Records after duplicates removed 
(n =  115) 
Titles and abstracts screened 
(n =  115 ) 
Records excluded 
(n =  90) 
Full-text articles assessed for 
eligibility 
(n = 24) 
Full-text articles excluded: 
Focus not on NIV (n= 5) 
Quantitative data only (n=3) 
Full text unavailable in English (n = 3) 
Focus on health care professional (n=2) 
MND not reported separately (n=1) 
Studies included in 
qualitative synthesis 




The JBI QARI Data Extraction Tool for Qualitative Research (Appendix 1.3) was used to 
standardise the process of recording relevant information from each article.  
Quality Appraisal 
There is a lack of consensus around how best to evaluate the quality of qualitative research. 
Majid and Vanstone (2018) reviewed a range of quality appraisal tools for qualitative research 
and produced a guide to selecting appraisal tools, which was utilised to select the Critical 
Appraisal Skills Programme (CASP) Qualitative Checklist (2018; Appendix 1.4). This has been 
identified as appropriate for novice researchers and is a widely used tool with clear guidelines 
to follow. The researcher and an independent reviewer (Trainee Clinical Psychologist) initially 
reviewed a sample of two studies, where agreement between reviewers was 80%. 
Discrepancies were discussed and resolved, resulting in full agreement between reviewers. 
Both reviewers then reviewed the remaining eight studies, with an agreement of 94%.  
The quality rating was not used to exclude studies with a low-quality score as it has been 
recognised that appraisal may be influenced more by how much detail the authors have been 
able to describe the methods in and the quality of the report rather than the procedure in 
qualitative research (Atkins et al., 2008). The potential impact of study quality on findings was 
considered as part of the synthesis.  
Method of Synthesis 
Meta-ethnography is a form of interpretative synthesis developed by Noblit and Hare (1988) 
and is the leading approach to qualitative synthesis within healthcare research (University of 
Stirling & NHS Quality Improvement Scotland, 2011). It is particularly well suited to integrating 
data from studies looking at patient experiences and allowing new insights into these, as it 
allows for the re-interpretation of conceptual data rather than simply providing a description 
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of findings. Meta-ethnography is therefore suitable to synthesise qualitative research 
exploring the experiences of NIV in MND patients and carers, which will add value to the 
existing review on this area.  
Sattar et al (2021) recently developed a practical guide to conducting meta-ethnography 
based on the stages set out by Noblit and Hare, in order to improve clarity and guidance for 
the synthesis process. This paper was used to guide the process of the seven steps of the 
process of meta-ethnography (see Appendix 1.5). An additional data extraction form was used 
to record the themes, first order constructs (participant quotes) and second order constructs 
(primary author interpretations) for each study. Synthesis should ideally involve both 
reciprocal translation, where themes in one study can incorporate those of another, and 
refutational translation, which looks to explain and explore differences between studies. 
Synthesis may also represent a line of argument. Common themes and concepts were then 














Table 1 summarises the ten papers included. Studies explored MND patient and carer 
experiences of non-invasive ventilation and issues surrounding this intervention. Three studies 
specifically examined experiences of decision making about NIV (Ando et al., 2014b; 
Greenaway et al., 2015; Lemoignan & Ells, 2010), with Ando et al. (2014b) focusing specifically 
on experiences of declining or withdrawing from NIV. Two studies looked at MND patient and 
carer experiences of NIV (Baxter et al., 2013b; Sundling et al., 2009), while two other studies 
(Baxter et al., 2013b; Winther et al., 2020) focused specifically on carer experiences. Baxter et 
al. (2013c) specifically examined carers’ and health care professionals’ experiences of end-of-
life care with MND patients using NIV (although only carer experiences were included in this 
study). Two studies focused on the perspective of MND patients (Young et al., 1994; Ando et 
al., 2014a), with Ando et al. (2014a) focusing on how this changed over time. 
Participants were all MND patients or carers who had considered NIV as an intervention or 
had either accepted or rejected NIV. Eight studies were qualitative and two were mixed 
methodology, with all studies using semi-structured interviews to collect data. Six studies 
were conducted in the UK, two took place in Canada and the remaining two were conducted 
in Denmark and Sweden.  
Quality Appraisal 
The quality of studies was evaluated using the CASP Qualitative Checklist (2018; see Appendix 
1.3). See Appendix 1.6 for a summary of responses. All studies provided a clear statement of 
the aims of the research and why this was relevant. This was not as clearly set out in Young et 
al. (1994). Qualitative methodology was appropriate in all studies. The research design of all 
studies was appropriate in addressing their aims. However, four studies did not explicitly 
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justify how they decided which method of qualitative analysis to use (Baxter et al. 2013a; 
Baxter et al. 2013c; Sundling et al. 2009; Young et al. 1994).  
The recruitment strategy was appropriate in all studies. All studies collected data in a way that 
addressed the research question. However only two studies (Baxter et al. 2013b and Baxter et 
al. 2013c) explicitly discussed saturation of data. Four studies did not adequately consider the 
relationship between researcher and participants (Baxter et al. 2013a; Baxter et al. 2013b; 
Baxter et al. 2013c; Greenaway et al.2015). All other studies discussed collaboration with 
colleagues, separate research and clinical roles or acknowledged any bias present.  
All studies stated that they had received approval from an ethics committee with the 
exception of Young et al. (1994). This study did discuss consent and ethical standards in 
research. Three studies did not describe how the research was explained to participants 
(Greenaway et al. 2015; Lemoignan & Ells 2010; Young et al. 1994) and only half of the studies 
considered the effects of the study on participants (Ando et al. 2014b; Baxter et al. 2013a; 
Baxter et al. 2013b; Baxter et al. 2013c; Sundling et al. 2009).  
Reports of data analysis were rigorous in the majority of studies, with the exceptions of 
Winther et al. (2020) and Young et al. (1994). Additionally, another three studies did not 
adequately discuss their potential bias in the analysis process (Greenaway et al. 2015; 
Lemoignan & Ells, 2010; Sundling et al. 2009). All studies presented a clear statement on 
findings, however three studies (Baxter et al. 2013c; Sundling et al. 2009; Young et al. 1994) 
provided limited critical appraisal. Four studies (Baxter et al. 2013c; Greenaway et al. 2015; 
Sundling et al. 2009; Young et al. 1994) provided limited or no suggestions for further 
research. Overall, the quality of studies was generally good, with some areas of exception in 








What the study 
examined 
Design Methodology Participants Main themes  
Ando et al. 
(2014a), UK 
How patients’ 
perceptions of NIV 
treatment evolve over 
time and how this is 
reflected in their 




N =5, patients with MND 
using NIV for 12+ months 
51-75yo (M=59) 
4 male, 1 female 
1. Experiences of NIV: physical-psychological 
relationship 
2. Influence on attitude 
3. Perceived impact of NIV on diagnosis  
Ando et al. 
(2014b), UK 
Why some patients 




N =9, patients with MND 
who had declined or 
withdrew from NIV  
40-79yo (M=67) 
7 male, 2 female 
 
1. Preservation of the self 
2. Negative perceptions of NIV 
3. Negative experiences with health services 
4. Not needing NIV 
 
Baxter et al. 
(2013a), UK 
Whether patient use of 
NIV impacted on their 
family carer, and to 










N= 16, family carers of 
patients with MND 
Ages of patients ranged 
from ‘under 60’ to ‘70+’, no 
mean given 
12 female cares, 3 male, 1 
unspecified 
 
1. Carer perceptions regarding the impact of 
noninvasive ventilation 
2. Carer perceptions regarding sources of burden 
3. Role change and patient needs 
4. Difficulty having time away 
5. Acceptance of professional help 









What the study 
examined 
Design Methodology Participants Main themes  
Baxter et al. 
(2013b), UK 
Experiences of patients 
with MND and their 
carers following the 





N = 20 patients, 17 carers. 
Patients aged from ‘under 
60’ to ‘70+’, M=67) 
No ages for carers 
15 male patients, 5 female. 
11 female carers, 3 male, 3 
unspecified 
 
1. Potential barriers 
2. Perseverance 
3. Perceived benefits 
 
Baxter et al. 
(2013c), UK 
Carer and health 
professional experiences 
of end-of-life care of 






N =9 family carers. Data 
from HCPs not extracted  
Patient age: ‘60+’ to ‘70+’, 
no mean age given.  
6 female cares, 3 male 
1. Unexpected speed of deterioration  
2. Hospitalisation versus dying at home 
3. Attempts to resuscitate 
4. Decision-making regarding the withdrawal of NIV* 
5. Peaceful final moments 
6. Turning off the machine 
7. Professional uncertainty regarding the use of NIV* 
8. Positive impacts of NIV use 
9. Concerns regarding NIV use* 
*These themes were not included in the review as they 
applied to healthcare professionals only.  
 
Greenaway 
et al. (2015), 
UK 
Factors associated with 
decisions made by 
patients with 
amyotrophic lateral 
sclerosis (ALS) to accept 







N=21 total, N= 5 who 
decided about NIV  
3 participants were 
interviewed with carers 
present.  
NIV participants:  




1. Perceptions of choice  
2. Acceptance and need  
3. Aspects of fear* 
External factors 
4. HCPs: Doctors, nurses, therapists, care workers  
5. Family*  
6. Information  
7. The Concept of Time 








What the study 
examined 




The experiences of 
decision-making about 





N =9 total  
N using/making decisions 
about NIV = 8 
NIV patients: 
5 male, 3 female 
36-72yo (M=54) 
1. The Meaning of the Intervention 
2. The Importance of Context 
3. The Importance of Values  
4. The Effect of Fears 
5. The Need for Information 
6. Adaptation To or Acceptance of the Intervention 
Quotes/interpretations from patients solely using long term 














N=7, 5 male and 2 female 
45-73yo (no mean given) 
 
Caregivers 
N=8, 6 female and 2 male 
40-74yo (no mean given) 
Patient Experiences 
1. Getting to know the ventilator 
2. Embracing the ventilator  
3. Being on a ventilator on a 20-24-h basis 
Caregiver’s Experiences 
1. Getting to know the ventilator 
2. Embracing the ventilator 






experiences of relatives 
of people with 
amyotrophic lateral 
sclerosis (ALS) living at 
home with mechanical 





N=11 total, N=9 carers of 
patients using non-invasive 
mechanical ventilation 
only/at some point in illness 
Carers – 5 female, 4 male 
Ages not specified  
1. We are in this together until the end 
2. Vulnerable relatives fighting to keep a track of 
everything 
3. Formal caregivers – a distressing relief 
4. A prison without personal space 
 
Quotes and interpretations were only included from 










What the study 
examined 
Design Methodology Participants Main themes  
Young et al. 
(1994), 
Canada 
Issues of the use of 
mechanical ventilation 














thematic analysis  
N=13. 11 older than 55yo, 2 
younger than this (no mean 
provided) 
11 male, 2 female 
4 of 13 participants were 
using mechanical 
ventilation, with 3 of these 
being on NIV 
The other participants were 
being asked to considered 
mechanical ventilation 
1. Quality of life 
2. Severity of disability 
3. Availability of ventilation by means of a nasal mask 
4. Possible admission to a long-term care facility 
5. Ability to control discontinuation of ventilation 
6. Desire to live 
7. Concerns for the emotional health/burden of care of 
family members 
8. Feelings about the ventilator 
Any quotes specific to invasive mechanical ventilation 




The meta-ethnography process elicited 5 super-ordinate themes through reciprocal translation (see 
Appendix 1.7); 1) Attitudes and coping styles; 2) Balancing discomfort with benefits; 3) Impact of 
continuing deterioration; 4) Fear and uncertainty; and 5) Challenges of professional support. The five 
superordinate themes and subordinate themes are detailed in Figure 2. All themes which emerged 
from lower quality studies were consistent with themes which emerged from studies of a higher 
quality. 
Figure 2 
Superordinate and subordinate themes 
 
1. Attitudes and coping styles 
The majority of studies reported on patient and/or caregiver attitudes towards MND and NIV, and 
how these influenced coping styles. 
 
 
1. Attitudes and 
Coping Styles















3. Impact of 
continuing 
deterioration
4. Fear and 
uncertainty 












  1.1 Desire to live and acceptance. The importance of living was highlighted by many patients, with 
NIV seen as essential to survival. Some patients viewed this essentiality as reflective of a lack of 
choice (e.g., Greenaway et al., 2015). Acceptance of MND appeared to be linked with acceptance of 
interventions as patients wished to live for as long as they could. It was highlighted in Lemogian & 
Ells (2010) that acceptance is a gradual process of repeated adaptation, involving familiarisation with 
equipment. The importance of perseverance was highlighted in a couple of papers; if patients 
experience that it allows them to live their life as they would want to, this can increase acceptance 
(e.g., Ando et al. 2014). Coping strategies such as problem solving and living in the moment 
appeared to be linked to psychological benefits of NIV and facilitate further adaptations such as 
acceptance of support. Caregivers reported acceptance of the disease, allowing them to come 
alongside patients as a collective “we”. 
“I would like to live and living (sic) as long as I can”. Patient (Ando et al., 2014a) 
“We’re dealing with things as we have to, and it’s probably not a bad way of going about it. And 
just thinking I’ll worry about it when it gets here. I can’t worry about it before.” Patient 
(Greenaway et al., 2015). 
  1.2 Reluctance and resistance. Resistance to accepting MND seemed to result in patients being less 
likely to accept NIV, for the same reason that people did accept it: a desire to maintain normality as 
much as possible, with acceptance of NIV being seen as giving into MND. These patients viewed NIV 
as prolonging an inevitable death. Ando et al. (2014a) found that there can be a shift in this attitude 
over time for some patients, particularly if they experience benefits of intervention. This view 
appears to reflect a resistance to perceived changes in identity and independence, and a desire to 
maintain control. Resistant patients equated preservation of life to a loss of dignity, dependence on 
others and an unacceptable quality of life. While they expressed a desire to live, living with NIV was 
seen as “not really living”. Some resistant patients perceived that they did not require assistance, 
despite noticing changes to their breathing.  
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“I've got a strong desire to live...but not with a ventilator." Patient (Young et al., 1994) 
2. Balancing discomfort with benefits.  
Most studies reported on the initial discomfort of using NIV, and/or the benefits that patients and 
caregivers experienced from its use over time.  
  2.1 Initial Discomfort. It was common for patients to describe a negative first impression of using 
NIV. There are various aspects of NIV which can cause discomfort; the mask and strap, mask sores 
and lesions were identified as ongoing difficulties. 
A common source of distress was air pressure, with this sensation feeling too powerful or making 
patients feel like they could not breathe. Mouth dryness was also common. Initially, patients and 
carers may feel as if life is dominated by the ventilator until this becomes integrated into their 
routine. Carers and patients experienced an initial issue with noise and/or interrupted sleep. This 
alongside the responsibility of motivating patients to use the ventilator, an initial lack of familiarity 
with the ventilator and frustration around its functioning can result in negative emotions. It appears 
that many disadvantages become easier with continued use, but some discomfort persists. 
“It did seem to take over, that became extremely important. But as the time’s gone on, as I say, 
we’ve got a lot more relaxed with it.’’ – Carer (Baxter at al., 2013a) 
  2.2 Perceived benefits. Improved sleep was the most commonly reported physical benefit for both 
patients and carers. Patients also reported improved energy levels, reduced shortness of breath and 
that it maintained their ability to communicate. These factors impacted on psychological wellbeing 
as patients had more energy to engage in valued activities e.g., visiting family, carrying out daily 
activities and living at home. NIV was generally perceived as improving quality of life as a result. NIV 
was described as eliciting feelings of relief and relaxation. Patients identified that a benefit of NIV 
was that it was a “no risk” decision as it was non-invasive and easy to discontinue, making it more 
acceptable than tracheostomy. 
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Carers experienced similar feelings of relief reported by patients. Carers described NIV as being easy 
to use and maintain. Studies found that carers benefitted from seeing the positive impact of NIV on 
patients and encouraged its use. They experienced less anxiety around the patients breathing and 
had more short periods of time to complete activities for themselves. In one study, carers reported a 
peaceful death for patients on NIV, with no choking or struggling for breath (Baxter et al., 2013c). 
Some carers were unsure about whether the minimal benefits their relatives received from NIV was 
worth the effort, but as a whole NIV was commonly experienced as beneficial for everyone. 
‘‘The whole family is at peace. Everything’s changed. He’s safe and I can relax. It’s…almost…perfect.’’ 
Carer (Sundling et al., 2009) 
3. Impact of continuing deterioration 
The course of MND was often experienced by patients as unpredictable, making decision making 
around interventions for both the present and the future difficult. This could be perceived as having 
little or no choice when accepting an intervention such as NIV, as it became a necessity. Conversely 
the uncertainty of decline and its impact in MND made others completely unable to accept or reject 
and intervention. Deterioration appeared to result in increased awareness of disease progression for 
some patients, which impacted on decision making.  
“…with ALS there’s no ruler.. .to measure where you’re at. . .. It’s not being able to know what’s 
normal or what’s next.” – Patient, Lemogian and Ells (2010) 
Increasing deterioration was associated with changes in roles for both patients and carers, with 
more responsibility placed on caregivers in terms of practical tasks and physical demands. NIV itself 
did not appear to be a significant contributor to carer burden. Carers experienced changes as being 
so gradual that they were difficult to identify. Winther et al. (2020) highlighted behavioural changes 
can be even more difficult for carers than practical challenges.  
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“I didn’t realise how quickly he would go down, I really didn’t. But I’m thankful that he did.” – Carer, 
Baxter et al. (2013c) 
4. Fear and Uncertainty 
Almost all studies touched on fears that patients experience about using NIV, and how the 
uncertainty of MND influences decision making.  
  4.1 Fear of dependence and loss of autonomy. Being in control of their condition and decision 
making was important to patients. Some patients felt that they had little choice around accepting an 
intervention, either due to healthcare staff or because of the disease itself.  
A common experience for patients across studies was the fear of becoming dependent on NIV, with 
some patients viewing acceptance of NIV as giving in, or being concerned about NIV causing more 
rapid deterioration. Ando et al. (2014b) found that this view changed for some people after using 
NIV for a period of time. NIV could be seen as a loss of autonomy and therefore a challenge to one’s 
identity and resulting in a lesser quality of life, both which could be viewed as unacceptable. This is 
contradictory to patients who reported one benefit of NIV as choice and feeling in control e.g., a 
choice to discontinue. 
Carers experienced loss of autonomy, with less control and choice over their own lives as the disease 
of the patient progressed. Carers also emphasised the importance of feeling involved and in control 
of decision making around interventions.  
"The main thing is being totally dependent on a machine and not being able to control my own 
destiny." Patient, Young et al. (1994) 
  4.2 Fears influencing decisions. Feelings of claustrophobia were a common potential issue of NIV 
use identified across studies, and patients identified worrying that NIV use was unbearable or 
unnatural. Other fears were broader, such as fear of deterioration, death and the future, and the 
uncertainty surrounding these. Some patients feared having no other choice than to use NIV.  
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“It’s scary having something like that on your face I think. And I’d imagine it’s quite claustrophobic as 
well; yeah, just having to wear that thing – doesn’t sound very nice to me.” – Patient, Ando et al. 
(2014b) 
5. Challenges of professional support 
Some patients described difficult experiences with healthcare professionals (HCPs) and felt the 
service they received was poor. For some patients this was linked with disengagement and refusal of 
interventions. Some patients experienced HCPs as persistent about interventions, which could be 
seen as a threat to autonomy. Overwhelming numbers of appointments and feeling like there was 
no other choice than to trust the expert also added to this sense of threat. Others felt that HCPs 
were supportive and helped with the decision-making process by providing reassurance. Winther et 
al. (2020) found that carers could feel neglected and undervalued by HCPs. 
“…I know they’re all at it, trying get me to change my mind – even though really I think it’s my 
decision. And I have tried to tell them. I do say the same thing every time I go there.” Patient, Ando et 
al. (2014b) 
Carers reported experiencing a burden of responsibility for both providing care and for coordinating 
between multiple agencies. Support from professional carers was difficult for carers to accept and 
presented additional challenges. Carers felt a responsibility to train and support professional carers, 
and found it difficult to trust their loved one’s care to others. Common experiences were worry, 
guilt, lack of privacy and frustrations over communication issues. These additional stressors 
appeared to become increasingly challenging as patients deteriorated.  
“….it is a great invasion – that suddenly there are people in your home all the time” – Carer, Winther 






This systematic review examined available evidence exploring the experiences of being offered non-
invasive ventilation as part of treatment in Motor Neurone Disease (MND), from the perspectives of 
both patients and carers. The synthesis identified five superordinate themes; 1) Attitudes and coping 
styles; 2) Balancing discomfort with benefits; 3) Impact of continuing deterioration; 4) Fear and 
uncertainty; and 5) Challenges of professional support. 
Acceptance appeared to be linked to positive coping strategies. Findings suggest that the acceptance 
of NIV was related to the acceptance of having MND, but recognised that this is a complex and 
dynamic process. There can be a change from resistance to acceptance over time. This may reflect 
the ‘response shift’, a concept first integrated into health related quality of life research by 
Sprangers and Schwartz (1999). The response shift has been used to explain why quality of life in 
progressive conditions such as MND can remain relatively high and stable. The response shift is an 
important part of how people adapt to a chronic illness, involving the mechanisms of recalibration, 
reprioritisation and reconceptualisation to bring their expectations in line with reality (Sprangers & 
Schwartz, 1999). In MND, people face continuing deterioration and therefore ongoing adaptation to 
what they are able to do independently, with support or not at all. Simmons et al. (2015) highlighted 
that this deterioration can result in a change from physical functioning having the biggest impact on 
quality of life, to other factors unrelated to physical functioning which are important to people (e.g. 
family, friends, interests and purpose). Oh et al. (2021) reported that avoidant strategies were 
commonly used in earlier disease stages of MND, while acceptance was associated with later stages. 
This review suggested that the utilisation of coping strategies is a constant process through the 
disease course as people adapt to both short- and long-term stressors. Lazurus and Folkman’s (1984) 
stress and coping theory differentiates between emotion focused and problem focused coping. They 
suggest that coping is situation dependent, with emotion-focused strategies used when situations 
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feel more uncontrollable (e.g., with increased deterioration) whereas problem-focused strategies 
are used in more controllable situations (e.g., when people learn more about the impact of such 
deterioration). 
This shift may influence whether patients are able to focus on the discomfort caused by an 
intervention such as NIV or on the benefits over time. It was common for patients and caregivers to 
focus initially on how uncomfortable NIV can be, with benefits appreciated over time as patients saw 
how it could help them to engage in valued activities. A scoping review of supportive care needs of 
MND patients and carers (Oh & Kim, 2017) identified that practical needs (including with assisting 
devices such as NIV) were most frequently reported. This was linked to informational needs, such as 
education around disease progression, treatment, and home-based caring skills. Education was 
found to reduce carer burden and information on what to expect with NIV may be beneficial for 
patients and carers and help them to persevere with treatment. Greenaway et al. (2015) highlighted 
the importance of information being individualised and coming from a variety of sources, while 
Baxter et al. (2013b) found a preference for in person or telephone support over written 
information. Patients in Lemoignan & Ells (2010) wanted ongoing information as the disease 
progressed.  
Disease progression brings uncertainty for patients and carers, which can make decision making 
difficult. Role changes also occur, with carers experiencing increased responsibility. The experience 
of uncertainty has been documented in MND, beginning when people are seeking a diagnosis 
(Remm et al., 2019). Uncertainty has also been identified as a difficulty for carers, who need to 
constantly adjust to changing demands including assistive interventions and anticipating equipment 
needs (Anderson et al., 2019).  
Fears that NIV use would be claustrophobic or unnatural were identified. For some patients, it 
appeared that assistive technologies further forced them to confront their own mortality. Fear of 
losing control and independence was the most prominent concern. Hobson et al. (2017) identified 
32 
 
resistance to specialist assistive technology which led to avoidance of thinking about or accessing 
this support even if this was seen as useful. Requiring specific interventions can be perceived as 
reaching unwanted milestones. It is important for people to maintain control and autonomy where 
possible while living with a disease which removes this. It may be that people maintain autonomy 
through acceptance and preparation for the future, or by avoidance and focusing on the present. 
Soundy & Condon (2015) found that autonomy influenced wellbeing across different stages of the 
disease. One element of this was difficulty in accepting interventions and devices as this could be 
seen as giving into MND, which can influence how people view themselves. 
The importance of autonomy was linked to how patients and carers experienced professional 
support, as it was important for people to feel involved in decision making. Some patients reported 
the experience of services as poor, which could influence whether patients accepted interventions. 
Remm et al. (2019) found that poor experiences with HCPs could increase chances of 
disengagement. Patients also reported HCPs were persistent about interventions, limiting their own 
autonomy. Carers felt that responsibility was placed on them without recognition from HCPs. 
Additionally, support from carers came with a loss of choice around privacy. Higher levels of 
perceived control in caregivers have been found to predict lower caregiver distress (de Wit et al., 
2020). 
Limitations  
No carers in the included studies reported challenges around coping with behavioural and emotional 
changes in MND patients, with the exception of one participant in Winther et al. (2020). Insight into 
the difficulties that carers may face when making decisions about interventions such as NIV and in 
supporting the implementation of interventions at home when their relative has frontotemporal 
dysfunction/dementia would have been valuable. These difficulties are being increasingly recognised 




This review was limited to studies published in English; therefore, relevant papers may have been 
missed as two papers were excluded on this basis. The papers included span a period of 26 years, 
during which NIV will have changed considerably. Although studies were primarily conducted in the 
UK, studies from other countries were included where healthcare services may be experienced 
differently. However, themes were evident across studies and implications for services are 
important to highlight regardless of whether these are in place or not. 
Quality appraisal was conducted to highlight any limitations rather than to exclude studies from the 
synthesis. Lower quality studies may have influenced findings. However, themes in these studies 
were comparable to themes found in studies of a higher quality. 
Only information related to non-invasive ventilation was extracted from studies. Therefore, some 
information may have been missed. It would be useful for further studies or reviews to examine the 
difficulties that come between choosing between NIV and invasive ventilation (e.g., tracheostomy) 
or in progressing from invasive ventilation from NIV, as this experience is likely to come with 
additional challenges. 
Baxter et al. (2013a;2013b;2013c) likely interviewed the same participants across studies, therefore 
themes are likely to have been repeated. However, only one subordinate theme draws from all three 
of these papers, suggesting that there was variation between experiences. 
Implications 
Aspects of fear and uncertainty appeared to be exacerbated by lack of information to support 
patients and carers in their decision making. Patients can feel overwhelmed by the provision of 
information and support immediately after diagnosis (Soundy & Condon, 2015) highlighting the need 
for information to be provided as the disease progresses. Baxter et al (2019) highlighted the 
importance of early NIV intervention, and the challenges of implementing these findings. Patients 
are often resistant to interventions initially, but attitudes may change over time. Offering support 
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and training may help carers to feel like their needs and burden of responsibility are valued by 
healthcare professionals. Bergin & Mockford (2016) suggested that carer coping and quality of life 
can be enhanced when resources are shared between HCPs, carers, and patients. 
Results suggest that the experience of healthcare services can influence decision making. Additional 
research on what could improve patient experiences of healthcare could help to further inform this. 
Access to accurate information can help people to feel informed in their decision making, which in 
itself has been found to help build trust and engagement with HCPs in oncology settings (Campbell 
et al., 2010). Conversely, when patients feel they are not valued and involved in decision making this 
results in disengagement and potentially rejection of life-sustaining interventions. Exploring the 
holistic needs of individuals and carers, and framing benefits of NIV in terms of what has been 
identified as important to people (e.g., quality of life and valued activities) may increase the 
likelihood of patients accepting a NIV trial. See Table 2 for a summary of practical implications for 
health care professionals. 
Future Directions 
Further research on awareness of different coping styles and attitudes may help to identify suitable 
psychological interventions for patients and carers. A mindfulness-based stress reduction (MBSR) 
meditation program tailored to MND patients resulted in significant improvements in anxiety, 
depression, and quality of life both post-intervention and at follow up (Pagnini et al., 2017), with 
similar results found in an online mindfulness intervention for MND patients and caregivers (Pagnini 
et al., 2021), where caregivers reported lower levels of carer burden.  
A meta-analysis of interventions for family caregivers of cancer patients emphasised the importance 
of patients and caregivers receiving support simultaneously, since they will react to the diagnosis of 
cancer as a unit (Northouse et al., 2010). The impact one has on the other was highlighted, and that 
carer wellbeing provides patients with optimal care. Parallels can be drawn with this experience and 




Attitudes towards MND and NIV and related coping styles appear to be driven by the same goals; to 
maintain autonomy and control; a desire to live; maintaining an acceptable quality of life; not ‘giving 
in’; and maintaining self-identity. There may be a shift from resistance to acceptance in the long 
term, and while individuals deal with ongoing stressors. There may also be a shift from focusing on 
discomfort related to NIV, to focusing on the benefits. Uncertainty impacts on both patients and 
carers, who experience a loss of autonomy which complicates decision making around NIV. Fears 
played a role in rejecting or withdrawing from interventions. Loss of autonomy can also be 
experienced during interactions with professionals, resulting in disengagement. 
Recommendations for clinical practice focused on improving person centred care for both patients 
and carers. This review has focused on the experiences of MND patients and caregivers who have 
been offered or have used NIV, with the hope that by improving HCPs understanding of this 












Table 2.  
Summary of practical implications for Health Care Professionals 
Area Specific practical implications/recommendations  
Information provision • Information should be individualised and tailored to the individual. 
• Information should be provided at point of diagnosis – but this can 
be overwhelming and patients and carers may need to have this 
explained again. 
• Patients and carers may need time to process information and to 
formulate questions. Having access to reliable printed or online 
information may help. 
• Information should be provided on an ongoing basis, with 
opportunities for patients and carers to ask questions.  
• Information should be provided on what to expect when beginning 
NIV in terms of discomfort, and on the potential benefits of using 
NIV.  
 
Education and support • Providing information or training sessions to carers around how to 
operate NIV machinery may help to reduce initial anxiety and carer 
burden. 
• Ongoing support should be offered to both patients and carers, in 
general and when using an intervention. If services are unable to 
provide this, signpost to relevant helplines. 
• Providing support to patients and carers in parallel may help to 
improve patient outcomes.  
• Assist in reducing discomfort as much as possible e.g., support with 
mask fitting. 
 
Autonomy • Patients should be supported to make their own informed 
decisions. 
• Patients should be offered choice of interventions on an ongoing 
basis, as their attitudes may change over time.  
• The provision of accurate information can help patients to feel 




• If patients feel that they have autonomy in decision making and are 
well informed, this may help to build engagement. 
• HCP understanding that attitudes and perceptions of interventions 
may change over time may help them to provide more person-
centred care.  
• Acknowledging the demands on carers may also help to improve 
relationships with patients and carers. 
• Exploring the holistic needs of patients and carers and explaining 
the benefits of NIV in terms of what is important to them may 
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Chapter Two: Major Research Project 
 
Experiences of Distress in Motor Neurone Disease and Views on an Adapted 
Distress Thermometer and Concerns Checklist: An Interpretative 
Phenomenological Analysis 
 
Prepared in accordance with the author requirements for the International Journal of 
Qualitative Studies on Health and Well-being (see Appendix 1.1, p.85) 
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Plain English Summary 
Background 
The Distress Thermometer (DT) and accompanying Concerns Checklist (CC) are tools which have 
been shown to be useful for screening distress and supporting health conversations across a range 
of health conditions (Snowden et al., 2011). Motor Neuron Disease (MND) covers a group of 
uncommon diseases that affect the brain and nervous system, and which involve muscle weakness 
which continues to become worse over time. People can also experience changes in their cognition, 
behaviour and communication abilities. It is important that distress is monitored in MND, as needs 
change quickly and patients have to adapt to a decline in their abilities, an increase in their 
dependence on others and changes across all domains of their lives (Sakellariou et al., 2013). Whilst 
the experience of psychological distress in people with MND is considered to be understandable it 
remains poorly understood and previous research has not examined how people with MND view DT 
and CC. 
Aim 
This study aimed to explore the lived experience of, and the meanings associated with, distress for 
people with MND. It is hoped that the results of this study may help to improve the understanding of 
distress in MND and help us to understand how people with MND experience the use of the DT and 
CC in screening for distress.  
Method 
A small number of people with MND (n=6) took part in semi-structured interviews. These interviews 
were then transcribed, and the data was analysed using a technique called Interpretative 







There were six main themes identified from the analysis; 1) diagnosis related distress; 2) support 
influencing distress; 3) the distress of uncertainty; 4) loss of independence and roles; 5) coping with 
MND and distress; and 6) views of the MND tool. 
Conclusions 
Participants discussed how difficult it is to deal with ongoing uncertainty and multiple losses 
experienced in MND. They spoke about the impact that personal and professional support can have 
on distress. Participants reported coping by focusing on positives of the past and present. Findings 
highlight the need for person centred care, which can be improved by the use of tools to screen for 
distress and identify concerns in MND. Recommendations which may increase person centred care 
and the identification of distress are discussed, such as providing information tailored to individuals; 
increasing awareness of MND in non-specialist health services; and training healthcare professionals 
to use the DT and CC. 
References 
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To explore the lived experience of, and the meanings associated with, distress in the context of 
Motor Neurone Disease (MND). 
Methods 
Phenomenological approach to understanding the experience of distress in MND and whether the 
Distress Thermometer (DT) captures this experience. Semi-structured interviews were conducted 
with people with MND (n=6) who were recruited from an MND clinic.  
Results  
Six superordinate themes emerged from the Interpretative Phenomenological Analysis: 1) diagnosis 
related distress; 2) support influencing distress; 3) the distress of uncertainty; 4) loss of 
independence and roles; 5) coping with MND and distress; and 6) views of the MND tool.  
Conclusions  
Findings highlighted the pervasive nature of uncertainty, multiple losses in MND and the impact that 
personal and professional support can have on distress. Participants reported coping by focusing on 
positives of the past and present, and on maintaining normality. Findings highlight the need for 
person centred care, which can be improved by the use of tools to screen for distress and identify 
concerns in MND. Recommendations which may increase person centred care and the identification 
of distress are discussed, such as providing individualised information; increasing awareness of MND 
in non-specialist services; and training healthcare professionals to use the MND DT. 






Psychological distress is commonly used as an indicator and outcome of mental health, but the 
concept remains unclear as it is applied to various symptoms, behaviours, and difficulties (Drapeau 
et al., 2012). Distress has been defined in a healthcare context as ‘a multi-factorial construct 
involving a complex interplay between biological, psychological, interpersonal, social, and existential 
factors’ with an emphasis on taking all of these aspects into account (Brennan et al., 2012, p. 1346). 
It has been proposed that the term can encompass general worry, fears, sadness and spiritual or 
existential crises as well as mental health problems (Holland & Bultz, 2007). Measurement of distress 
has been recognised as important across different clinical populations and health care settings due 
to the negative impact it can have on outcomes such as treatment seeking, quality of life, treatment 
adherence and survival rates (Ransom et al., 2006; Donovan et al., 2014; Faller et al., 1999; Holland 
& Alici, 2010).  
While often overlooked within physical health care settings, distress has long been recognised as the 
sixth vital sign within oncology care, with 25-60% of cancer patients reporting experiencing distress 
when asked (Zabora et al., 2001). The National Comprehensive Cancer Network (NCCN) developed 
the Distress Thermometer (DT; initially developed by Roth et al., 1998) and accompanying Concerns 
Checklist (CC), and advocate for the routine screening of distress. The DT is a visual screening tool 
where individuals are asked to rate their level of distress over the past week using a 0 (no distress) 
to 10 (extreme distress)-point Likert scale. Alongside this, the CC allows patients to indicate the 
source(s) of their distress under categories such as physical, practical and relationship problems.  
These tools have been shown to be useful for screening distress and supporting health conversations 
across a range of health conditions in clinical practice (Snowden et al., 2011). Brennan et al. (2012) 
highlighted the importance of using tools as part of a structured, collaborative discussion in order to 
effectively identify and reduce distress in patients. Healthcare conversations contribute to quality of 
patient care (Hemsley et al., 2015). It is particularly important to ensure that communication is 
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effective when people experience communication difficulties as these individuals often do not 
receive support that they require (Wylie et al., 2013). One study found that both clients and 
professionals found preparation and structure helpful in reaching a shared understanding, with 
which tools such as the DT and CC may assist (Stans et al., 2018).  
Various studies have established the validity of the DT as a tool to detect distress in cancer patients 
by comparing the DT to other screening measures (e.g., Ma et al., 2014; Gessler et al., 2007). A 
scoping review (Sousa et al., 2021) identified misuse of the DT in non-cancer populations, with 66% 
of studies using the DT without a concerns checklist, which contradicts recommendations for its use 
(Cutillo et al., 2017). As a result, the clinical utility of the DT in non-cancer populations remains 
unclear. Sousa et al. suggested that it was reasonable for concerns checklists to be adapted to 
specific conditions, and that the DT was both an appropriate and acceptable screening tool for 
distress across conditions. The DT is currently recommended as a screening tool for epilepsy 
(Scottish Intercollegiate Guidelines Network, 2018) and chronic respiratory disorders (e.g., COPD; 
Makuch et al., 2020).  
MND covers a group of neurodegenerative diseases which primarily involve the progressive 
deterioration of motor neurones, which control voluntary muscle movement e.g., movement, 
speech, breathing and swallowing (Young et al., 2019). These impairments often lead to increased 
dependency, changes to lifestyle and relationships (Trail et al., 2009). Neuropsychological deficits 
affect over 50% of people with MND, and these can vary considerably. Revised criteria for 
frontotemporal dysfunction MND have been expanded to incorporate the concept of a 
frontotemporal spectrum disorder to accurately reflect changes in executive function, language, 
memory, and behaviour which can occur in MND (Strong et al., 2017). Little is known about distress 
related to these changes as many studies focusing on wellbeing have excluded participants with 
cognitive or behavioural changes; however, behavioural changes have been linked to hopelessness 
in patients and increased caregiver burden (Caga et al., 2019). 
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People with MND experience a wide range of psychological reactions, such as anxiety, hopelessness, 
and distress (Averill et al., 2007). Depression and psychological distress have been found to be 
unrelated to disease progression or time since diagnosis (Rabkin et al., 2005). Psychological distress 
can reduce survival rates and quality of life, and increase interest in hastened death (McDonald et 
al., 1994; Johnston et al., 1999; Ganzini et al., 2002). The experience of psychological distress in 
people with MND remains poorly understood. Standardised measures examining distress often fail 
to address patients’ holistic needs, instead focusing on depression and anxiety.  
It is important that distress is regularly monitored in MND, as patients and their families face 
challenges in coping with uncertainty on a daily basis. Needs change quickly with existing symptoms 
progressing as new ones develop, as patients continuously have to adapt to a decline in their 
abilities, an increase in their dependence on others and changes across all domains of their lives 
(Sakellariou et al., 2013). Bulbar symptoms lead to impairment of speech and affect up to 30% of 
people with ALS (Haverkamp et al., 1995). Communication difficulties change over time and have a 
significant impact on quality of life; it has been identified by MND patients as a key factor in 
maintaining or losing their independence (Gruis et al., 2011; Green et al., 2013). 
In line with the National Institute for Health and Care Excellence (NICE, 2016) guidelines, which state 
that the psychological and emotional impact of MND should be discussed during assessments, The 
Motor Neurone Disease Clinic (MNDC) in NHS Ayrshire and Arran (NHS A&A) developed and 
introduced the DT with an adapted Concerns Checklist (CC; Appendix 2.1) in 2017 to be administered 
routinely at appointments. This tool allows patients to address physical, cognitive, emotional, 
practical, and social needs, and ensures that clinicians enquire about distress.  
However, there are additional challenges to identifying psychological and emotional needs in the 
MND population due to communication difficulties and cognitive impairment. MND services that 
have audited the use of adapted versions of the DT and CC have found that these tools have allowed 
patients to identify unmet needs and prompted further referrals (Wright et al., 2011) and that these 
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were acceptable to both patients and clinical staff (Lennox et al., 2018). However, individuals may 
experience screening differently. A systematic review found that when screening identified distress 
in cancer patients but provided no follow up care, there was no benefit of screening (Mitchell, 2013). 
This was in contrast with studies which demonstrated improved patient outcomes when screening 
was linked with mandatory referral or intervention. Stewart-Knight et al. (2012) emphasised the 
importance of conducting qualitative interviews in order to understand experiences of distress, what 
factors contribute to distress and how this is reflected in the DT. This is likely to be a particularly 
useful approach when the experience of distress within a particular disease, such as Motor Neurone 
Disease (MND), is not well understood. 
Aims 
The aim of the research was to better understand the lived experience of, and the meanings 
associated with, distress in the context of MND. It also aimed to understand patient views on the DT 
and CC for MND.  
Research Questions 
i) What are MND patient’s experiences of distress, if any? 
ii) What is the meaning of distress for individuals with MND?  
iii) What are MND patient’s views on using the Distress Thermometer and Concerns 











This study was approved by the Research and Development Department in NHS Ayrshire and Arran 
(reference number CM/KLB/CI 2020AA070; see Appendix 2.2) and NHS West of Scotland Research 
Ethics Committee (reference number 20/WS/0157; see Appendix 2.3). All participants gave verbal 
consent after receiving the consent form (Appendix 2.4) prior to interview, which was recorded 
before commencing interviews. Relevant data protection regulations were followed to ensure study 
data was stored securely. 
Design 
A qualitative design utilised Interpretative Phenomenological Analysis (IPA) methodology to explore 
and analyse the lived experiences of people with MND. Participants took part in a semi-structured 
interview.  
Recruitment 
The MND team were provided with information about the study (Appendix 2.5), identified eligible 
participants and informed them about the study. Those interested consented to their contact details 
being passed on via an opt-in form to the researcher (Appendix 2.6), who then contacted them to 
discuss the details of the study, what participation would involve, and to arrange a suitable interview 
time. Participants were sent the Participant Information Leaflet (Appendix 2.7), instructions on how 
to access Attend Anywhere, a copy of the consent form for their information and the distress 
thermometer and concerns checklist. Participants were asked to look over the DT and CC prior to 
interview. Participants were not previously known to the researcher. 
Participants and Sample Size 
Six participants were recruited in NHS Ayrshire and Arran at the MND clinic within the Douglas Grant 
Rehabilitation Centre. One other person agreed to be interviewed and sent information, but phoned 
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to cancel their interview for reasons unknown. Inclusion criteria were Diagnosis of Motor Neurone 
Disease; registered and seen within the Motor Neurone Disease Clinic; cognitive capacity to 
communicate informed consent; aged 18 years or older, ability to verbally communicate. Exclusion 
criteria: inability to communicate consent or lack of cognitive capacity to give consent as identified 
by the clinical team; communication difficulties which would be considered too difficult to 
understand via audio recording.  
The method of IPA is typically based on, and is best suited to, small sample sizes involving individual 
interviews of participants. In IPA research purposive sampling is normally used in order to have a 
homogenous sample. This approach was used as much as possible given the small population of 
people with MND. The study sought to recruit 6-8 participants as this is the recommended sample 
size for doctoral level research projects (Turpin et al., 1997). Due to constraints on recruitment such 
as a low number of clients meeting inclusion criteria, data saturation was not considered. 
Data Collection 
Interviews were carried out between April 2021 to June 2021. One interview was conducted with 
each participant by the primary researcher (R.K.) Participants were given the option of having 
multiple, shorter interviews if required. No other individuals were present during interviews and no 
repeat interviews were carried out. Interviews took place over Attend Anywhere due to Covid-19 
restrictions. An interview schedule (Appendix 2.8) was developed by the researcher in consultation 
with study supervisors, including a Consultant Clinical Psychologist working within the MND team. 
The schedule was also informed by the literature and included open questions with additional 
prompts. The schedule was used flexibly in line with IPA methodology (Smith et al., 2009). Interviews 
lasted between 40 minutes and 1 hour and 55 minutes. Interviews were audio-recorded after 
participants provided consent for this, before being transcribed verbatim. The researcher regularly 
checked in with participants in case of fatigue and/or distress. All potentially identifiable information 




Interpretative Phenomenological Analysis (IPA) was used to analyse data as it aims to explore 
participants’ experiences, understandings, and perceptions, and assumes that participants seek to 
interpret their experiences into a form which is understandable to them. This method allowed 
research questions relating to people with MND’s experiences of distress to be addressed.  
The researcher utilised guidance from Smith et al. (2009) to analyse the data. Following verbatim 
transcription, interviews were listened to and read repeatedly by the researcher to become 
immersed in the data. Line-by-line analysis was then completed in order to note linguistic, 
descriptive, and conceptual themes. The next stage of analysis involved identifying themes, before 
identifying comparisons and contradictions of themes across participants. Throughout the analysis, 
the researcher moved back and forward through the transcript to reflect on what had previously 
been said, to interpret individual transcripts and all transcripts more fully as a whole. This was to 
ensure the double hermeneutic principles of IPA were incorporated into analysis as much as 
possible. Quotations were selected where they were thought to best capture the nature of the 
theme or where they provided particular insights. Samples of the transcripts were reviewed by one 
of the researchers to ensure that similar themes were identified (sample in Appendix 2.9).  
Researcher Reflexivity 
IPA places emphasis on researcher reflexivity, acknowledging that interpretations of data are tied to 
the researcher’s ability to reflect and analyse. This is particularly important in this study as the 
researcher has no personal or professional experience of MND, therefore engaging in reflective 
practice allowed the researcher to reduce the impact of preconceptions on interpretations. The 
researcher is a female, trainee clinical psychologist with experience of qualitative methods (not IPA). 
The researcher logged personal thoughts in a reflective journal to ensure reflexivity after each 
interview and during analysis (sample in Appendix 2.10). In line with IPA, the researcher approached 





Four participants lived with a partner and two participants lived alone with support from 
professional carers. Two participants had a slower progressing form of MND (30 years and 11 years 
since diagnosis). Mean time since diagnosis for the remaining participants was 1.3 years. Three 
participants were male (Andrew, Ben, and Tom) and three were female (Jane, Marion, and Sophie), 
with an average age of 73. One participant used a voice output device to communicate. Individual 
demographics are omitted due to risk of participant identification.  
Qualitative Interviews 
Six superordinate themes and ten subordinate themes emerged from the analysis, as summarised in 
Table 1.  
1. Diagnosis related distress 
The first superordinate theme details how participants made sense of their diagnosis. Two 
interrelated subthemes were identified. 
  1.1 Distress when anticipating and receiving diagnosis. All participants reported distress around 
waiting for and/or receiving a definitive diagnosis. Three participants stated that they had been 
aware of MND being a potential diagnosis. Tom, Anthony, and Ben reported feeling completely 
shocked, particularly Ben who had not known what MND was.  
“…it sort of hits you like a brick wall. My god how did this happen, you know…I didn’t know about 
MND. Didn’t have a clue” Ben. 
Ben’s use of “hit me like a brick wall” emphasises the sudden and significant negative impact of his 
diagnosis. Sophie and Jane reported feeling less initial shock as they had been expecting MND, with 
Jane feeling that the uncertainty of waiting for a confirmed diagnosis was almost as distressing as 
the diagnosis itself.  
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“I didn’t know, until I got the diagnosis. Which was… you know, pretty hard in itself…but em, after all 
I’d been through it, um…it was worse probably, but, em…only slightly…” Jane 
Participants all experienced fearing the worst, which was defined by suddenly confronting their own 
mortality. Fears also included how quickly they would deteriorate, and how they would cope with 
MND.  
“…this is going to end my life prematurely, and between now and when that happens, I’m just going 
to get worse and worse and be able to do less and less. So…that was the distress.” Sophie 
Similar thoughts were described by Marion, “…I was going to die, my life was finished.”, alongside 
the sense of there being no hope regarding treatment or cure. Both Andrew and Tom experienced 
the same initial distress. However, they both were eventually informed that their condition was 
progressing much slower than usual. 
“Once I realised that it wasnae something…it wasnae going to happen tomorrow, I realised I could 
cope with it and I tried to act as normally as I possibly could.” Andrew 
There was a sense of them gaining back some control, and not experiencing the same sense of 
uncertainty as participants with a typical MND presentation.  
  1.2 Clinicians causing distress. Four participants experienced distress as a result of interactions 
with clinicians. Ben and Sophie had felt overwhelmed by the amount of information that they had 
received.  
“Different teams, different medical people, were talking to me about different things…And I thought, 
yeah, alright, I know. And I think it was just one thing after another and it just was all stacking up 
and then it just all collapsed and it was just too much…” Sophie 
The way that Sophie describes this experience demonstrates the impact of these stressors quickly 
building over a short time period. Ben reported being told “virtually everything” at the start which 
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increased his distress and experience of uncertainty. There was a sense of being forced to confront 
the reality of the diagnosis before being ready to do so (“yeah, alright, I know”). 
Tom and Jane experienced anger and frustration when dealing with clinicians. Jane described a GP 
misdiagnosing depression, despite her not experiencing low mood. Jane reported feeling frustration 
at how her own concerns were dismissed and feeling like she wanted vindication for this, stating 
“I’ve always wanted to go back and say, I told you I wasn’t depressed”.’ Tom reported wishing to 
have his consultant struck off for the blunt manner in which his diagnosis was delivered to him.  
“…a complete lack of empathy, he had no understanding of my potential agenda in a case like that, 
he was delivering, what was bound to be, life changing news, to a patient, and to a patient’s family, 
in an offhand way, without having anything to back it up, other than his…literally 5 minute 
examination of me.” Tom 
It was evident that Tom felt like he had not been involved in the diagnosis, describing feeling like a 












Table 1.  
Superordinate and Subordinate Themes  
Superordinate Subordinate 
Diagnosis related distress Distress when anticipating and receiving diagnosis – “…I was going 
to die, my life was finished.”  
 
Clinicians causing distress – “I thought it was absolutely dreadful 




Valued support networks – “Everybody rallied round to help me.” 
 
Importance of specialist support – “People are oblivious to the fact 
it exists.” 
 
The distress of uncertainty Uncertainty as losing control – “You just never know.” 
 
Covid-19, MND and uncertainty – “…nobody could come here, 
nobody could visit, it’s all had to be masks.” 
 
Loss of independence and 
roles 
 
“I’m very independent. I don’t like depending on anybody.”  
 
Coping with MND and 
distress 
Focusing on the positives – “You have to keep positive or you lose 
everything.” 
 
Maintaining normality and identity –“I’m still me.”  
 
Views of the MND Tool Reflecting experiences of MND – “It covers, most subjects to talk 
about, aye.”  
 
Enhancing person-centred care – “You’ve got the option to say, 










2. Support influencing distress 
The second superordinate theme considers the importance of both personal and professional 
support. There were two subthemes. 
  2.1 Valued Support Networks. All participants discussed the importance of support from family and 
friends. For Marion, Jane, and Sophie, this had been what they had been most grateful for, using 
variants of “fortunate” or “lucky”.  
“I can’t imagine how people that haven’t got support around them…So I feel quite fortunate 
basically, I feel very lucky.” Sophie 
This sense of support being essential was reflected, with Ben reporting that his family “do 
everything” for him, Tom describing how “everybody rallied round” to help him and Jane stating that 
she “couldn’t have asked for more” from her friends and family. Tom and Ben both described family 
members as being advocates for them.  
“I still can fight my own corner, most of the time, but having a family member there helps me.” Tom 
This highlights Tom’s desire to keep on doing as much as he can independently, while recognising 
that he will increasingly require support. Both Ben and Sophie described going through MND with 
their family, using “we” frequently, particularly when discussing coping with MND. 
“We’re all battling through it.” Ben 
Interestingly, it was also these two participants who discussed worrying about becoming a burden 
on their families and expressed guilt about having to depend more on their family. 
“…it’s only really him[husband] that I massively effect, um, so, so I do feel guilty about that.” Sophie 
Sophie repeated “guilty” when expressing not wanting to burden her adult children. Jane also 
alluded to this, reporting that her adult daughter had “her own things to contend with”. Ben 
reported being concerned about “all of the extra work” that he feels that he is passing onto his 
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family). Andrew also described the “frustration” of having to depend on his wife to carry out specific 
tasks for him. This highlights that although support is seen as positive and essential, it can also elicit 
difficult emotions. 
  2.2 Importance of Specialist Support. Specialist support, such as the MND team and MND Scotland 
was seen as person centred, knowledgeable, helpful, and responsive to people’s needs. Andrew 
reported having a positive experience of all services involved in his care, but was particularly positive 
about the MND team. 
“Anything I’ve asked them for they’ve...managed to provide…what I needed. There’s someone on the 
end of the phone if I need them, eh…it makes me quite…quite happy, aye.” Andrew 
It appeared that having support available helped him to maintain some control. Tom echoed this 
experience of the MND team and highlighted their collaborative approach as being particularly 
beneficial (“…they participate with me in any discussions and I’m included in things”). Tom discussed 
the uncomfortable need to gradually pass control to professionals, and reported that still feeling 
involved made this easier. Ben also emphasised his appreciation of collaborative care, describing 
appointments at the MND clinic as being “50/50”. Marion acknowledged that this was “…usually 
better, more successful, than other interactions” , and echoed Andrew’s sense of control in knowing 
that there is “…support for most situations”. Ben highlighted the role of reliable support in helping to 
reduce worry and distress.  
“The only positive thing I can say is to do with the MND team…I’m not worried about anything at all 
and it’s all down to those people.” Ben 
Andrew and Tom, who both have slower progressing MND, had very strong views on the general 
lack of awareness of MND particularly in comparison to other conditions. 
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“…cause it’s not cancer…it’s motor neurone disease, and people don’t know what to do about that. 
Most people are not aware of what that is, even, and…they don’t regard it as being, any kind of a 
priority…So you just get dealt with in the queue.” Tom 
Tom emphasised the lack of awareness specifically being around timing of support. Jane reported 
non-specialist services as not providing person-centred care and having a lack of awareness of MND:  
“… you know, they don’t understand about MND or…I’m just a, you know, body at the bed….” Jane 
Jane and Sophie reported that specialist supports were much more responsive when providing 
adaptations but that generally their provision felt like “…reacting rather than anticipating”. Jane 
acknowledged the possibility of patients feeling “despondent” if given adaptations too quickly. 
Sophie contrasted specialist and non-specialist services to emphasise the difference in 
responsiveness: 
“…I can just ring [MND nurse] and she sets the wheels in motion and things happen… but [non-
specialist service]…that’s been a long time, when I really needed it more then…” Sophie. 
3. The distress of uncertainty 
The third superordinate theme highlights the inherent distress of uncertainty in MND. Two 
interrelated subthemes were identified. 
  3.1 Uncertainty as losing control. The difficulty of living with uncertainty as part of MND was 
reported by all participants with the exception of Tom (“…I don’t dread it at all.”) who has slower 
progressing MND, which appeared to alleviate uncertainty. In contrast Andrew, did find the 
experience of uncertainty around deterioration distressing.  
“The uncertainty of when it is going to happen is uh…the most, most sort of, concerning thing. I 
mean, it might be a while yet, I don’t know when it will be, and that’s…that’s the thing.” Andrew 
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The way Andrew explains this demonstrates the back and forward nature of his thoughts. All five 
participants struggling with uncertainty described variants of “you just never know” and “you don’t 
know what’s coming”. Marion highlighted that this uncertainty is pervasive: “…it is difficult to live 
with daily.” Ben and Jane both emphasised that changes come quickly and unexpectedly. For Ben, 
physical changes felt constant and unpredictable.  
“You know… totally unexpected things happen. Like my speech, my mobility, my breathing, um… loss 
of power in my hands and arms…legs, you know, it’s just progressing, one thing after another” Ben. 
This again highlights that uncertainty is a constant presence in people’s lives. Jane emphasised that 
even when you aware of what changes you are likely to experience, you cannot predict the impact 
these will have on you or how you will cope when these changes happen. 
“I knew I would get worse…but, um, it’s only really when you’re going through it you realise, at…at 
each stage how it affects what you can do. I’m just, at the stage of, how will I cope if I’m any worse.” 
Jane 
For all participants, there was a sense of this uncertainty resulting in a sense of feeling like nothing 
was in their control. Sophie in particular emphasised the difficulties of not being able to make plans 
due to how quickly deterioration can occur.  
“But you can’t move forward, you can’t make plans, you can’t make plans at all. Um, yeah, it’s 
difficult not being able to plan anything, so that’s hard, that’s distressing.” Sophie 
Sophie also struggled with the loss of the plans she had for her future. Uncertainty is one of the main 
areas of distress that people with MND have to cope with as it is an inherent part of the progressive 
nature of the condition.  
  3.2 Covid-19, MND and uncertainty. Three participants (Ben, Jane, and Sophie) had received their 
diagnosis during the coronavirus pandemic. Covid-19 related restrictions and lockdowns were 
perceived as both exacerbating MND related uncertainty and as masking changes. These participants 
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viewed the experiences of MND and going through covid as being intertwined and hard to 
distinguish between. 
“Yeah, it all came at the same time, so I can’t really…differentiate between getting MND and going 
through covid, it’s all came at the one time. So going through both at the one time, that’s all we can 
do.” Ben 
Ben used “we” to highlight that he got through both with his family. Having a common experience of 
uncertainty with others appeared to be helpful for Sophie. 
“…they were limited by covid restrictions and I was limited by MND and covid, but, you know, they 
were restricted and now all of a sudden everybody’s out doing stuff…” Sophie 
For Sophie, this shared uncertainty of Covid-19 had eased the uncertainty around her MND, as 
others had not noticed the impact of her being able to do less. However, she also acknowledged that 
Covid-19 made it even more difficult to make plans, and how she may have spent her time 
differently if she had been diagnosed at another time. Jane reflected on what she could do before 
lockdown compared to now, and therefore restriction emphasised changes for her. She also noted 
similarities between lockdown and MND both making days difficult to distinguish between.  
“With lockdown it’s hard to tell which day of the week it is (laughs). Every day is much the same, it’s 
the same routine and I have to stick to a routine because the carers come… according to a schedule.” 
Jane 
4. Loss of independence and roles 
All participants reported finding loss of independence as a result of MND distressing. Andrew’s fear 
of uncertainty centred around when he would need a wheelchair, and this appeared to be his 
biggest source of distress due to a fear of losing his independence.  




The fear of losing mobility was understandably linked with a fear of losing independence. Tom 
described how he could still walk, but weakness in his upper limbs had left him with a fear of falling.  
“I’m afraid of falling, I know that if I do fall, if I fall that way, that will be the end of me…” Tom 
This portrays a sense of Tom feeling that if he falls, he will lose mobility and be unable to do 
anything independently. “…the end of me” demonstrates how dreaded an outcome this would be for 
him. Andrew reported finding it distressing and frustrating to have to rely on family members to 
perform tasks he would normally do himself, “I get very frustrated cause I cannae do that.” Andrew 
viewed himself as someone who had always been independent, therefore gradually losing this ability 
was the most distressing consequence of MND. Similarly, Ben found this loss of control and 
increasing need to depend on his family to be distressing.  
“… I used to do virtually everything for them, and now the tables turned completely and they’re 
having to do everything for me. So that is hard to get your head round and to accept. Yeah.” Ben 
This description demonstrates how much this was experienced as a complete role change for Ben, 
which has felt difficult to comprehend. There was a sense that for most participants, being able to 
function independently was inextricably linked with their identity. Sophie and Jane both experienced 
a loss of independence. 
“…I was self-sufficient, with help, and now I’m not.” Sophie 
Sophie’s description emphasises that she was previously able to do everything herself, and how this 
has quickly declined. Sophie and Jane also found it difficult that their role had shifted from 
supporters to being supported, particularly as grandparents not being able to support their children:  
“I used to be able to go and help my daughter at times…or other members of the family I used to try 
and help but…I can’t do all that now...” Jane 
There was a sense of guilt for not being able to physically provide support for family members, as 
well as a loss of not being able to participate in family roles as expected. For Marion, her loss of 
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independence came from losing her ability to verbally communicate. She described how this 
impacted her ability to be involved in activities independently.  
“You need to verbally communicate. You feel vulnerable in certain situations…. And people relate to 
you in a different way, not as an equal. Probably because I have no voice.” Marion 
Marion’s description suggests that losing her voice has resulted in losing her ability to be involved 
and to feel in control in social situations, therefore feeling more dependent on others. Marion also 
described how fatigue results in a frustrating disparity between what she wants to do and what she 
has the energy to do independently.  
5. Coping with MND and distress 
The fifth superordinate theme describes how people cope with MND and distress. Two interrelated 
subthemes were identified. 
  5.1 Focusing on the positives. A coping strategy for all participants was to focus on the positives in 
the past or present rather than on the difficulties of MND or the uncertainty of the future. There was 
a sense of this being the only choice that people had and that this was a conscious effort to choose 
to focus on the small positives.  
“I always try and think…think positive and I try not to think about…about the unpleasant thing. But 
it’s not that I… put my head in the sand, you know, you can’t forget them, but you just have to, 
concentrate on the good things, you know…getting outside to see the daffodils... ” Jane 
Jane emphasises that it is not about avoidance, as this is impossible. This demonstrates that people 
still feel distressed, but that concentrating on the positives is more helpful than thinking about what 
they have lost. There was a sense of people trying to make the most of the time that they had left 
rather than thinking about what they no longer have.  
“There are many losses, but you have to look for new positives and be grateful.” Marion 
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Andrew and Ben emphasised that this is a conscious effort (“I don’t let things get me down.” 
Andrew) and simultaneously the only choice to avoid further distress (“…there’s nothing I can do 
except accept it and try to carry on....” Ben). Jane, Sophie, and Tom all reported finding it helpful to 
reflect back on the positive experiences they had throughout their lives.  
“…despite everything, we’ve been quite lucky, well, whether you call it lucky, we’re really, you know, 
happy with what we’ve managed to do so far.” Sophie 
This portrays that people are able to manage some of the distress they are experiencing in the 
present by focusing on pleasant memories from their past (“…remember that you had all these good 
times.” Jane), creating a sense of being satisfied with the life they have lived (“I’ve done all the things 
that I wanted to do.” Tom).  
  5.2 Maintaining Normality and Identity. Accepting MND for people meant accepting but not giving 
in to the diagnosis. Participants reported coping by trying to do as much as they could for as long as 
possible.  
“… if I can fight it by…trying, trying to talk, walk about, do things with my hands and arms, if I can do 
it, I’ll carry on, until I can’t do it anymore.” Ben 
Maintaining normality seemed to give people a sense of control by not giving in. Sophie emphasised 
the importance of still planning some things and trying to adapt to ongoing changes, but how this 
can be difficult when their adaptations stop working. 
“…you think you’ve got something sorted out, and it all comes crashing down, and then you end up 
quite low. Until you get up the next morning and you think, right, we’ll have to find something else to 
do. And you attack it and get started again, you know, trying to find ways to keep doing things.” 
Sophie 
This sense of not giving in appeared to be what motivated people to stay in the present, and to 
remain positive, involved and in control. Andrew and Tom had both made adaptations to their 
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homes themselves, anticipating what problems they would be facing in the future in an attempt to 
maintain normality and a sense of control for as long as possible.  
“Being proactive obviously doesn’t change things or the likely outcome of things, but it enables you 
to go on staying in control as much as you can for as long as you can.” Tom 
Maintaining normality allowed participants to feel like they were still in control in the face of 
uncertainty, and part of this was maintaining their own identity. All participants reported that 
although MND has impacted on them physically, MND has not impacted on their identity (“I’m still 
me” Jane). This appeared to be a source of strength that people drew upon, with participants 
describing themselves as “…quite a confident person. I’m quite positive” (Andrew), “a coper and 
problem solver” (Sophie), “a very proactive person” (Tom) and “I’m not one for just packing up” 
(Ben).  
6. Views of the MND Tool 
The final superordinate theme portrays participant’s views of the MND Distress Thermometer (DT) 
and Concerns Checklist (CC). There were two interrelated subthemes.  
  6.1 Reflecting experiences of MND. All participants described the DT/CC tool as useful or helpful, 
and felt it covered relevant areas. All participants stated that they did not feel that was anything 
missing, with three participants describing the tool as comprehensive.  
“I think it’s very useful, to have a structured approach.” Tom 
Three participants commented that they felt that their own concerns fit into the checklist, although 
Sophie stated that she could not pick concerns to prioritise as they were all being dealt with. Jane 
reported that the categories were a helpful memory prompt for concerns that may not affect people 
all the time, but found the idea of rating her distress on a scale to be difficult. 
“It’s hard to…categorise things, things such as feelings, but…it’s very hard to um, quantify.” Jane 
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 Both Sophie and Ben reported worrying about areas that were not affecting them now potentially 
impacting on them in the future. However, this did not appear to be overly distressing; Sophie 
reflected that the list could remind people of what they can do, and that she was already aware of 
the possible changes. Ben felt that he would be able to cope with any changes that came his way, as 
he had been doing.  
“So you’ve got a few things down there which make you wonder. It really could make you worry. As 
I’ve said, anything that’s for me, will come this way, and I’ll just accept it and carry on the best I can.” 
– Ben 
6.2 Enhancing person-centred care. All participants agreed that the tool would be useful to guide a 
discussion with their HCPs. All participants referred to the importance of the tool being used to 
ensure people are able to discuss their concerns. Four participants felt that they would not need to 
use the tool to raise concerns, but felt that the tool would be particularly helpful for giving control 
and choice to people who find it difficult to raise issues with HCPs.  
“I can still do that [speak up for himself]…But many patients won’t be able to do those things, and 
obviously to have something structured for them is something that could help them to do that.” Tom 
Marion and Tom both felt that a potential issue with the tool could be HCPs being unwilling to use 
the tool collaboratively. It is worth noting that these participants had experienced some HCPs as 
being unempathetic or as very directive.  








The current study explored the lived experience of distress in the context of MND. Additionally, 
MND patients’ views on using the Distress Thermometer and Concerns Checklist were examined. 
Following IPA analysis, six superordinate themes emerged: i) diagnosis related distress, ii) support 
influencing distress, iii) the distress of uncertainty, iv) loss of independence and roles, v) coping with 
MND and distress and vi) views of the MND tool.  
Consistent with existing research, the current study highlights diagnosis of MND as a point of 
distress, even when people desire a definitive explanation for symptoms (Remm et al., 2019; Aoun 
et al., 2016). A study exploring experiences of MND diagnosis found that factors which mediated 
distress were HCPs who treated patients as individuals and support from family and friends (Remm 
et al., 2019), reflecting findings in the current study. Aoun et al. (2016) highlighted neurologists 
specifically could improve patient experiences by demonstrating more empathy, increasing 
consultation times, decreasing follow-up periods, and sharing more information. In the current 
study, participants reported experiencing empathy and care from specialist services but not from 
general health and social care services.  
The importance of support from family and friends in alleviating distress was highlighted by 
participants. Research within palliative care has suggested that this support is a protective factor, 
the absence of which may identify patients at risk of struggling to cope (Milberg et al., 2014). 
Additionally, Leigh et al. (2021) found that MND patients with higher levels of social support had 
lower levels of psychological distress. Some participants were concerned about the burden their 
family caregivers may experience. However, qualitative research has found that family caregivers 
can also experience acceptance, gratitude, hope and happiness (Tan et al., 2020). This study 
highlighted the need for caregivers to be supported, and how HCPs can help by involving them in 
decision making and by communicating empathetically. 
70 
 
Participants felt there was a general lack of awareness of MND. Lack of knowledge from 
professionals has been identified as one barrier to diagnosis (Remm et al., 2019). Lack of awareness 
from HCPs can reduce the efficacy of advanced care planning, impacting on interventions patients 
receive (Murray & Butow, 2016). Participants in one qualitative study (Weeks et al., 2019) felt there 
was a lack of awareness, both societally and among non-MND clinicians, and similarly contrasted this 
with increased awareness of cancer. Participants reported that this led to inadequate provision of 
information and support, as well as feelings of isolation. 
The current study highlighted the need for person centred care, beginning while people are seeking 
a diagnosis. Paynter et al. (2020) described how decision making for some was seen as being limited 
to accepting or rejecting recommendations and having a choice around when to accept interventions 
rather than if. This feeling of not having control could be a barrier to shared decision making in 
MND. Person centred support can help people to maintain control over some aspects of their lives in 
the face of uncertainty, by remaining involved in their care (Warnock et al., 2017).  
Results reflect findings that the experience of uncertainty is pervasive and begins while seeking a 
diagnosis of MND (Remm et al., 2019). A study exploring uncertainty in MND (Harris et al., 2018) 
reflected themes in the current study around how maintaining control in the face of uncertainty 
through being involved in health care interventions can result in a further loss of control (e.g., need 
for professional carers). It also stressed how coping is easier for those who can accept the disease. 
The current study discussed the challenges that Covid-19 brought in terms of exacerbating 
uncertainty and exaggerating difficulties. Glasmacher et al. (2021) outlined the impact of the 
pandemic on MND patients, including anxiety around exposure, difficulties receiving support, 
loneliness, and fear of being denied treatment. This demonstrates the wider impact that Covid-19 
has had on people with MND. 
Loss of independence and roles for participants in the current study were identified as sources of 
distress. Soundy & Condon (2015) discussed changes to roles and independent living as major losses, 
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while Munan et al. (2021) connected these two experiences; people who experienced role reversal 
with their partner experienced a loss of independence. They also reported that role changes can 
result in a loss of intimacy with disease progression. Sakellariou et al. (2013) highlighted that people 
with MND have no control over the disease, but they can be supported to maintain control over 
their care and to feel as independent as possible. 
Participants in the current study reported coping with MND in similar ways to participants in Remm 
et al. (2019); by regaining control, and maintaining normality and identity for as long as possible, 
strategies also found in other studies (Soundy & Condon, 2015; Sakellariou et al., 2013). Some 
patients reported finding these methods of coping difficult in the face of feeling overwhelmed with 
their diagnosis. Ways of coping reported in the present study fit with the idea of an internal health 
locus of control e.g., by focusing on areas of their disease that they do have control over as opposed 
to aspects which are outside of their control (external locus of control). In cancer patients, an 
internal locus of control is associated with better coping strategies (Goldzweig et al., 2016). In a 
study which examined therapeutic approaches for people with MND (Rabbitte et al., 2015), most 
focused on supporting individuals to maintain an internal locus of control. It is likely to be more 
difficult to focus on an internal locus of control in a MND, where there is no hope for cure, but it may 
be beneficial for patients if they are supported to do so.  
Participants in the current study felt that the MND Distress Thermometer and Concerns Checklist 
were comprehensive tools which allowed for the facilitation of collaborative discussions. Some 
participants felt that clinicians may be resistant to using this, which reflected their own experiences 
of care not being person centred. Unfortunately, participants had not had the opportunity to use 
these tools in practice, although points raised reflected some of the experiences of cancer patients 
who had used the DT and CC. Biddle et al. (2016) found that patients found the tools useful in 
identifying and validating distress, improving holistic care, improving relationships with HCPs and for 
increasing the potential for concerns to be addressed.  
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Participant responses indicated that they may have specific concerns (e.g., about requiring a specific 
adaptation soon) without being distressed. However, participants discussed how concerns could 
turn into sources of distress if they were not addressed. Experiences of distress appeared to fit 
Brennan et al.’s (2012) definition, encompassing a range of factors which can cause distress. 
However, it is worth noting that Biddle et al. (2016) found that patients did not always report 
distress, as they defined this with regards to significant mental health difficulties rather than 
concerns impacting on their life and/or wellbeing. Sousa et al. (2021) discussed the importance of 
informing participants using the DT about the definition of distress. 
Strengths and Limitations 
These findings represent the personal experiences of a small, homogenous group of people with 
MND, which limits their generalisability. However, generalisability is not the aim of IPA, as this 
methodology seeks to gain an in-depth understanding of experiences. Samples of the transcripts 
were reviewed by one of the supervisors of this research to increase reliability. If resources had 
allowed, further measures could have been taken to limit subjectivity, such as researchers 
independently coding themes and reviewing themes with participants. The main strength of the 
study is the addition to the literature of a rich, descriptive phenomenology of distress in MND, which 
can inform practice and research.  
Recruitment proved difficult, due to demands placed on the MND team and the additional demands 
of the Covid-19 pandemic. MND clinicians acknowledged feeling apprehensive about approaching 
patients as they did not want to place another demand on people. This may have resulted in a bias in 
recruitment, where participants are people who have been more able to cope with the distress of 
MND. Participants may have felt that they had to be positive about the MND team, although they 
were reassured that the study was independent from the clinic prior to interview. Originally this 
study would have sought to explore their personal experiences using the tool, but unfortunately this 
has not been used as part of clinical appointments due to the majority of appointments taking place 
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remotely. This may have resulted in participants being unclear about the use of the tool. IPA would 
have been appropriate to explore participants ’lived experiences of using the tool, and it was 
decided that it would still be useful to interview participants about how they felt the tool related to 
their experiences of distress. However, as participants did not experience using the tool it may have 
been more appropriate to investigate these views using a different method of analysis (e.g., 
thematic analysis) as using IPA for this aspect of the study did not provide the same rich, descriptive 
data as provided by the rest of the interview questions. 
Participants received support from the same specialist MND team, therefore many experiences of 
HCPs will be from the same service. However, local services would have covered a wider range of 
HCPs. Participants were of similar ages. People diagnosed with MND at a younger age may have had 
different experience of distress. The experience of distress in MND may differ depending on disease 
progression. Two participants had a slower progressing MND, which did appear to have an impact on 
their experiences of distress, although there were similarities to other participants’ experiences too.  
For one participant communication difficulties made an in-depth exploration of experiences difficult. 
This participant met inclusion criteria as they could verbally communicate using a voice output 
device. The use of alternate communication methods was out with the scope of this study, but 
would be a valuable addition to future research.  
Clinical Implications 
The findings of this study highlight the importance of person-centred care, which can help patients 
to maintain independence, which may enhance their ability to use helpful coping strategies. 
Increasing awareness of MND in non-specialist services may help HCPs to provide better care.  
Timely and accurate information about diagnosis, prognosis and treatment options can help patients 
to feel more empowered. Sakellariou et al. (2013) highlighted that it can be difficult to achieve a 
balance between both the amount and timing of information, with people preferring to deal with 
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problems as they come up rather than too far in advance. Information should be easily understood 
and individualised to the patient as much as possible to support this. This study highlighted the 
importance of family support, suggesting that there should be a collaborative treatment plan 
between HCPs, the patient, and their families.  
The nature of MND makes decision making challenging. Utilising tools such as the MND DT and CC 
can help patients to be involved in their care, maintaining a sense of control and independence 
which can help mediate the impact of uncertainty. These tools can enhance patient centred care by 
supporting discussions between HCPs, patients, and their families. Research on tools to involve 
patients in decision making indicate that their use can increase engagement, improve 
communication between patients and HCPs and reduce unnecessary treatment (Stacey et al., 2017). 
These tools should be subject to ongoing evaluation with the views of patients being incorporated.  
Services using the MND DT and CC should make this available online. This would allow the tools to 
be easily updated with new information, and allow patients to go through this with clinicians during 
phone or video appointments. Training should be provided to HCPs around how to use the tool in a 
collaborative manner and to ensure that they feel comfortable discussing distress. There should be 
clear pathways for clinicians around where to refer patients to for support if required. Tools should 
be administered frequently due to the rapidly changing nature of MND. 
Although further research is required around psychological interventions in MND, coping strategies 
described in the current study suggest that approaches such as Acceptance and Commitment 
Therapy (ACT) or mindfulness may be beneficial. Weeks et al. (2019) highlight aspects of ACT which 
may be beneficial to people with MND, such as a focus on increasing valued behaviour, and 






Increased understanding of information provision could allow HCPs to deliver more person-centred 
care. Future research could focus on participants’ experience of distress, care, and information 
provision longitudinally to see how these experiences change over time. Conducting interviews using 
different communication aids would assist with ensuring inclusion.  
Future research should focus on how both patients and clinicians experience using the MND DT and 
CC in order to identify benefits and barriers associated with its use. Biddle et al. (2016) found that 
clinicians and patients identified different barriers to using these tools in an oncology setting. 
Further research may want to investigate the validity of the MND DT or internal consistency of the 
MND CC. 
Clinicians may be wary about approaching patients about research participation. However, including 
people in research may enhance their feelings of being involved and autonomous, which would link 
in with identified helpful coping strategies in the current study. Research could investigate how 
patients with MND experience this.  
Conclusions 
This study sought to explore experiences of distress in patients with MND. Findings highlighted the 
pervasive nature of uncertainty, loss of roles and independence in MND and the impact that support 
can have on distress. Participants in the current study also demonstrated extraordinary resilience, 
reporting coping by focusing on positives, and on maintaining normality. Findings highlight the need 
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Appendix 1.2 Search Terms and Results by Database 
Embase  
1 Amyotrophic Lateral Sclerosis/ [SH] 
2 Motor Neuron Disease/ [SH] 
3 (motor neuron* disease or amyotrophic lateral 
sclerosis or MND or ALS).tw [Title or abstract] 
4 [MND Component] 1 OR 2 OR 3 
5 Noninvasive ventilation/ [SH] 
6 Artificial ventilation/ [SH] 
7 (non invasive ventilat* OR non-invasive 
ventilat* OR noninvasive ventilat* OR artificial 
respiration OR artificial ventilat* OR mechanical 
ventilat* OR NIV OR NPPV OR NIPPV OR 
positive pressure ventilat*).tw (title or abstract) 
8 [NIV component] 5 or 6 or 7 
9 Qualitative research/ 
10 Interview/ 
11[Qualitative filter] ((("semi-structured" or semistructured or 
unstructured or informal or "in-depth" or 
indepth or "face-to-face" or structured or 
guide) adj3 (interview* or discussion* or 
questionnaire*))).ti,ab. or (focus group* or 
qualitative or ethnograph* or fieldwork or 
"field work" or "key informant").tw,kw or 
qualitative research/ 
12 [qualitative component] 9 OR 10 OR 11 



















1 Amyotrophic Lateral Sclerosis/ [SH] 
2 Motor Neuron Disease/ [SH] 
3 (motor neuron* disease or amyotrophic lateral 
sclerosis or MND or ALS).tw [Title or abstract] 
4 [MND Component] 1 OR 2 OR 3 
5 Noninvasive ventilation/ [SH] 
6 Respiration, Artificial/ [SH] 
7 (non invasive ventilat* OR non-invasive 
ventilat* OR noninvasive ventilat* OR artificial 
respiration OR artificial ventilat* OR mechanical 
ventilat* OR NIV OR NPPV OR NIPPV OR 
positive pressure ventilat*).tw (title or abstract) 
8 [NIV component] 5 or 6 or 7 
9 Qualitative research/ 
10 Interview/ 
11 [Qualitative filter] ((("semi-structured" or semistructured or 
unstructured or informal or "in-depth" or 
indepth or "face-to-face" or structured or 
guide) adj2 (interview* or discussion* or 
questionnaire*))).tw,kw or (focus group* or 
qualitative or ethnograph* or fieldwork or 
"field work" or "key informant").tw,kw or 
interviews as topic/ or focus groups/ or 
narration/ or qualitative research/ 
12 [qualitative component] 9 OR 10 OR 11 

















1 DE “Amyotrophic Lateral Sclerosis” [SH] 
2 DE “Motor Neurons” [SH] 
3 TI ((“motor neuron* disease” or “amyotrophic 
lateral sclerosis” or “MND” or “ALS”)) OR AB 
((“motor neuron* disease” or “amyotrophic 
lateral sclerosis” or “MND” or “ALS”))  
4 [MND Component] 1 OR 2 OR 3 
5 DE “Artificial Respiration” [SH] 
6 TI ((“non invasive ventilat*” OR “non-invasive 
ventilat*” OR “noninvasive ventilat*” OR 
“artificial respiration” OR “artificial ventilat*” 
OR “mechanical ventilat*” OR “NIV” OR “NPPV” 
OR “NIPPV” OR “positive pressure ventilat*”)) 
OR AB ((“non invasive ventilat*” OR “non-
invasive ventilat*” OR “noninvasive ventilat*” 
OR “artificial respiration” OR “artificial 
ventilat*” OR “mechanical ventilat*” OR “NIV” 
OR “NPPV” OR “NIPPV” OR “positive pressure 
ventilat*”)) 
7 [NIV component] 5 OR 6 
8 DE “Qualitative Methods” 
9 TI ((("semi-structured" or semistructured or 
unstructured or informal or "in-depth" or 
indepth or "face-to-face" or structured or 
guide) n3 (interview* or discussion* or 
questionnaire*))) OR AB ((("semi-structured" or 
semistructured or unstructured or informal or 
"in-depth" or indepth or "face-to-face" or 
structured or guide) n3 (interview* or 
discussion* or questionnaire*))) 
10 TI (focus group* or qualitative or ethnograph* 
or fieldwork or "field work" or "key informant") 
OR KW (focus group* or qualitative or 
ethnograph* or fieldwork or "field work" or 
"key informant") 
11 [Qualitative component] 8 OR 9 OR 10 











1 (MH “Amyotrophic Lateral Sclerosis”)  
2 (MH “Motor Neuron Diseases”) 
3 TI ((“motor neuron* disease” or “amyotrophic 
lateral sclerosis” or “MND” or “ALS”)) OR AB 
((“motor neuron* disease” or “amyotrophic 
lateral sclerosis” or “MND” or “ALS”)) 
4 [MND Component] 1 OR 2 OR 3 
5 (MH “Respiration, Artificial”) 
6 TI ((“non invasive ventilat*” OR “non-invasive 
ventilat*” OR “noninvasive ventilat*” OR 
“artificial respiration” OR “artificial ventilat*” 
OR “mechanical ventilat*” OR “NIV” OR “NPPV” 
OR “NIPPV” OR “positive pressure ventilat*”)) 
OR AB ((“non invasive ventilat*” OR “non-
invasive ventilat*” OR “noninvasive ventilat*” 
OR “artificial respiration” OR “artificial 
ventilat*” OR “mechanical ventilat*” OR “NIV” 
OR “NPPV” OR “NIPPV” OR “positive pressure 
ventilat*”)) 
7 [NIV component] 5 OR 6 
8 (MH “Qualitative Studies”) 
9 TI ((("semi-structured" or semistructured or 
unstructured or informal or "in-depth" or 
indepth or "face-to-face" or structured or 
guide) n3 (interview* or discussion* or 
questionnaire*))) OR AB ((("semi-structured" or 
semistructured or unstructured or informal or 
"in-depth" or indepth or "face-to-face" or 
structured or guide) n3 (interview* or 
discussion* or questionnaire*))) 
10 TI (focus group* or qualitative or ethnograph* 
or fieldwork or "field work" or "key informant") 
OR MW (focus group* or qualitative or 
ethnograph* or fieldwork or "field work" or 
"key informant") 
11 [Qualitative component] 8 OR 9 OR 10 
































•Identify an area of interest within qualitative research1. Getting Started
•Define the focus of the synthesis
•Identify eligible studies
•Appraise quality of studies
2. Deciding what is 
relevant to the initial 
interest
•Become familiar with the themes in each study
3. Reading the 
studies
•Generate a list of themes for each study
•Examine relationships between concepts/themes
4. Determining how 
the studies are 
related
•Use these themes to translate the studies into one 
another
5. Translating studies 
into one another
•Studies are viewed as a whole




•Write up the synthesis following eMERGE and/or PRISMA 
reporting guidlines




Appendix 1.6 Quality Appraisal Responses for all Included Studies 
Study 1 2 3 4 5 6 7 8 9 10 Comments 
Ando et al. (2014) 
“Experience of…” 
Y Y Y Y Y Y Y Y Y Y Same study 
Ando et al. (2014) 
“Why don’t they…” 
Y Y Y Y Y Y Y Y Y Y 
Baxter et al. (2013) 
“The impact on…” 
Y Y Y Y Y N Y Y Y Y Same study 
Baxter et al. (2013) 
“The initiation of…” 
Y Y Y Y Y N Y Y Y Y 
Baxter et al. (2013) 
“The use of…” 
Y Y Y Y Y N CT Y Y Y 
Greenaway et al. 
(2015) 
Y Y Y Y Y N Y Y Y Y  
Lemoignan & Ells 
(2010) 
Y Y Y Y Y Y Y Y Y Y  
Sundling et al. 
(2009) 
Y Y Y Y Y Y Y Y Y CT  
Winther et al. (2020) Y Y Y Y Y Y Y CT Y Y  
Young et al. (1994) Y Y Y Y Y Y CT N CT Y  
 
Response: Yes (Y), No (N), Can’t tell (CT). 












Appendix 1.7 Themes identified from reciprocal translation during meta-ethnography. 
Theme Reciprocal Translation  Studies 
1.1 Desire to live and 
acceptance 
6 out of 10 Ando et al. (2014a) 
Baxter et al. (2013b) 
Greenaway et al. (2015) 
Lemoignan & Ells (2010) 
Winther et al. (2020) 
Young et al. (1994) 
1.2 Reluctance and resistance 5 out of 10 Ando et al. (2014a) 
Ando et al. (2014b) 
Greenaway et al. (2015) 
Lemoignan & Ells (2010) 
Young et al. (1994) 
2.1 Initial discomfort 6 out of 10 Ando et al. (2014a) 
Ando et al. (2014b) 
Baxter et al. (2013a) 
Baxter et al. (2013b) 
Sundling et al. (2009) 
Young et al. (1994) 
1.2 Perceived benefits 7 out of 10 Ando et al. (2014a) 
Baxter et al. (2013a) 
Baxter et al. (2013b) 
Baxter et al. (2013c) 
Lemoignan & Ells (2010) 
Sundling et al. (2009) 
Young et al. (1994) 
3. Impact of continuing 
deterioration  
 
5 out of 10 Baxter er al. (2013a) 
Baxter et al. (2013c) 
Lemoignan & Ells (2010) 
Greenaway et al. (2015) 
Winther et al. (2020) 
4.1 Fear of dependence and 
loss of autonomy 
 
8 out of 10 Ando et al. (2014a) 
Ando et al. (2014b) 
Baxter et al. (2013a) 
Baxter et al. (2013c) 
Lemoignan & Ells (2010) 
Sundling et al. (2009) 
Winther et al. (2020) 
Young et al. (1994) 
4.2 Fears influencing decision 
making 
 
5 out of 10 Ando et al. (2014b) 
Baxter et al. (2013b) 
Lemoignan & Ells (2010) 
Greenaway et al. (2015) 
Sundling et al. (2009) 
5. Experience of healthcare 
professionals 
 
8 out of 10 Ando et al. (2014b) 
Baxter et al. (2013)a 
Baxter et al. (2013b) 
Lemoignan & Ells (2010) 






















Sundling et al. (2009) 








1. Circle the number from     
0 (zero) to 10 (ten) that best 
describes how much distress 
you have felt in the past 
week, including today. 
 
Physical problems 
 Appearance   
 Bathing/dressing  
 Breathing  
 Bladder/bowel   
 Choking    
 Eating/drinking         
 Fatigue/tiredness        
 Movement/getting around 
 Pain    
 Sexual    
 Skin   
 Sleeping  
 Speech  
 Salvia management 
   
Relationships 
 Dealing with family or friends  
 Dealing with staff/carers  
 Roles and responsibilities 
  
Emotional problems 
 Worry/fear/anxiety   
 Sadness/depression 
 Sudden crying/laughing  
 Anger  
 Guilt  
 Denial                          
Practical problems 
 Child care        
 Finances    
 Housing    
 Transport/Driving  
 Work/activities 
 Legal issues 
 Aids and adaptations 
Cognitive problems 
 Concentration   
 Communication   
 Memory   
 Making decisions 






 Changes in behaviour/personality 
 Loss of interest or motivation   
 Loss of interest in how other feel  
 Change in food preferences 
Patient Name: ………………………… 
 
Date completed ………………………. 
2. Please tick any of the following that has been a cause of distress 
for you in the past week, including today. 
Motor Neurone Disease 
Concerns Checklist 
Spiritual 
 Spiritual concerns 
 Religious concerns   
Concern 1. 
3. If there are several concerns please identify which three would help you most to discuss at 
this time? 























MND Concerns Checklist – Management 
 
 Briefly describe the  
Patient’s concern. 
Any immediate action taken e.g. 
information clarified, verbal or 
written information  
given, referred to see other health 
care professional 
Any next steps 
required? 
e.g. Referral to 
other service, speak 
to MDT, seek advice 
Who is 
responsible 























     

























































Appendix 2.8 Interview Schedule 
Interview Schedule  
1. In relation specifically to the process of being diagnosed, what caused you the most 
distress?  
➔ What were your initial thoughts and expectations? 
 
2. What has caused you the most distress in relation to living with MND?  
➔ What changes have you found the most difficult? 
➔ How have you tried to cope with these? 
➔ What are the main differences between a good day and a bad day for you?  
 
3. Has having Motor Neurone Disease changed the way that you think or feel about yourself?  
➔ Do you see yourself differently now than before you received your diagnosis? 
➔ How do you think other important people in your life see you?  
 
4. How have any roles you previously held changed?  
➔ For example, in your relationships, working life or social activities.  
 
5. How well do you think that the distress thermometer and concerns checklist reflect areas 
which you have felt distressed (e.g. worried or upset) about? 
➔ What areas do you think are missing, or what would you add?  
➔ How useful did you find it/do you think it would be in helping to guide a conversation 
with your clinician about what is important to you?  
➔ How much control do you feel that you have in appointments with clinicians? 
 
6. Do you think that services have helped you with the things that you most wanted help 
with? Has there been anything that you wanted help with that services did not help you 
with?  
➔ Did you feel that your emotional needs and important areas in your life were discussed, 
as well as your physical health? 
➔ How would you describe your interactions with health care professionals? 
➔ What was helpful/unhelpful? 
 
7. What has your experience of uncertainty been like since your diagnosis? 
➔ In your day to day life? 




8. Have there been any positive aspects of your experience that you would like to tell me 
about? 




Appendix 2.9 Transcript Coding Example 
Emergent Themes Original Transcript Exploratory Comments 
Sense of control in 











Focus on positives 






I’m not a worrier 
Focus on identity 
Uncertainty difficult  





Hypervigilant to sings of 
feared things happening 
– maintaining control 
 
 
: That’s good, I can imagine that must make a difference.  
 
P: There’s someone on the end of the phone if I need them, eh… it 
makes me quite… quite happy, aye.  
 
I: I’m glad of that. I was wondering what your experience of 
uncertainty had been like since your diagnosis? 
 
P: Well the biggest uncertainty is… whether or when I’m going to 
end up in the wheelchair, eh, that’s the biggest…biggest one of… is 
it tomorrow or…am I going to end up having a fall and that’s me 
finished or… I mean, I started walking with basically, two walking 
sticks. But I kept falling and so I had to get this walker and I still fall 
now and again. But eh…I’ve no ended up in a wheelchair yet. No I 
cannae say there’s any uncertainty other than that… eh, no, no…I 
tend not to worry about other things.  
 
I: For you the uncertainty has, again, been focused on the 
wheelchair, and otherwise you’ve kept… managed to keep quite 
a positive attitude. 
 
P: Aye, aye I…tend to do that, I don’t let it get me down or worry 
me (mm hmm). The uncertainty of when it is going to happen is 
uh…the most, most sort of, concerning thing. I mean, it might be a 
while yet, I don’t know when it will be, and that’s…that’s the thing.  
 
I: Definitely, that’s the thing that might pop into your head and 
be a bit worrying.  
 
P: Every now and again, is this the start of it, every time I get a wee 
stiffness or a wee nerve I go, oh… is this the start of it. That’s it, 
that’s mainly…what I think in my head. 
Support there when needed. Sense of control in being able to reach out for 






Wheelchair as uncertainty. Sense of mobility being important to sense of 
identity, maintain independence but there has been a gradual loss of this. 
Ultimate fear is losing this completely or having a fall and losing more mobility 
Having a fall as being finished as this would result in needing a wheelchair and 
not physically moving himself, others having to do this.  
When will it happen, uncertainty reflected in how describing, jumping about in 
describing how this could happen. Worry about falling. Decline of ability to 
walk. No other uncertainty emphasised by repetition. I don’t worry about other 






Repetition as emphasising positive attitude. I don’t get down/worried. I am not 
a worried or down person, restating identity and how this is out the norm for 
him. Hesitant repetitive language reflecting this uncertainty.  
Uncertainty of when he’ll need a wheelchair as primary concern. Signals point 





A worry that’s sparked by physical symptoms. Hypervigilant to signs of feared 















Contentment over time 
End of the world initially 
 




Alternative reasons – old 
age, covid 




I: That’s understandable, you’re almost looking out for the signs 
because it’s so uncertain.  
 
P: I look for the signs, definitely…so I can find out when it can 
happen. I mean it might be 3 years before it happens. 
 
I: Do you think that experience of uncertainty has changed over 
time for you, because your diagnosis was so long ago? 
 
P: Aye, it probably has, I’m probably more…more content with the 
fact I’ve got it (uh huh) ….initially it was…uh, It was the end of the 
world sort of thing… but as the years went on…but for years 
there’s really been no change whatsoever, I’m just the same, 
nothing changed, all the same. But as I said, over the past couple 
of years… since the covid thing… we’ve all been less active, and 
I’ve been trying to move about more, maybe that’s one of the 
reasons, I dunno. So…I’ve given up the bowling, the bowling… that 
kept me active as well. And it’s maybe age, old age…. I have quite a 
positive attitude and I don’t…I don’t let things get me down  
 






Looking for the signs to find out when it happens. Realising it might not 
happen for some time. A strategy to maintain control. Pause reflects reluctance 





Contentment over time. Pauses reflecting trying to think about this experience 
in the past, a long time ago, becoming more fluid as it comes back to present 
do and how he feels now. Initial thoughts of it being the end of the world, end 
of who he was as a person. No changes as meaning he is just the same as a 
person. Repetition of nothing’s changed to emphasise this as being both no 
physically changes and no changes within himself.  
Reflecting on more recent changes, becoming more difficult to ignore. 
Attributing to potential alternative reasons, such as less activity during covid, 
old age. Hesitations suggesting difficulty believing these other reasons – it’s 
MND.  
Returning to who he is – I am positive, I don’t let things get me down and I am 







Appendix 2.10 Sample of Reflective Notes 
Reflection following interview with Marion 
Prior to our interview, I had been feeling quite overwhelmed about the prospect of trying to 
meet multiple demands involving placement, research, and social commitments, most of 
which were being made easier by the ability to effectively communicate with others. When we 
began our interview, I was struck by how long it took for Marion to type the response that she 
wanted so that this could be heard through her verbal output device. I was very conscious of 
ensuring I allowed plenty of time for Marion to say everything she wanted for each question, 
and both of these factors lead to long silences between us both speaking. Marion told me 
about how she can feel like others do not always treat her as an equal, as they are not willing 
to give her the same opportunity to speak. I enjoyed speaking to Marion, but came off the call 
thinking about how infuriating I would find that experience, which is now her normality.  
Marion had spoken about how she copes day to day, and had done this in such a poetic 
manner, despite her communication difficulties. She spoke about focusing on the small 
positives (“every day is a new day and the birds sing”), which I found to be really powerful 
when we had just been discussing how much life has changed for her as a result of her MND 
diagnosis. Again, I had the experience of feeling both privileged to discuss such personal 
experiences with someone who had chosen to give up their time for my research, and struck 
by the resilience of the people I am interviewing.  
It occurred to me that when Marion had been describing how she copes with her diagnosis 
and the ongoing uncertainty that this brings, she had been describing some principles of 
mindfulness. Reflecting back on previous interviews, similar principles had also been identified 
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Experiences of Distress and its Screening using the Distress Thermometer in Motor 
Neurone Disease 
Abstract  
Background. The Distress Thermometer (DT) is a screening tool used to help identify distress 
across health conditions. Motor Neurone Disease (MND) covers a group of neurodegenerative 
diseases which primarily involve the progressive loss of motor function, but can also result in 
cognitive, behavioural and communication impairments . People with MND and their families 
face daily uncertainty due to the nature of these changes. Whilst the experience of 
psychological distress in people with MND is considered to be understandable it remains 
poorly understood and previous research has not examined how people with MND view the use 
of the DT as part of their assessment.  
Aims. To better understand the lived experience of distress in the context of Motor Neurone 
Disease by exploring, i) participant experiences of distress within the context of a diagnosis of 
MND, if any; ii) the meaning of distress for individuals with MND; iii) participant’s views of 
the Distress Thermometer and Concerns Checklist in relation to their own experiences.  
Method. Semi-structured interviews will be conducted with people with MND. It is hoped that 
up to 6-8 participants will be recruited from the NHS Ayrshire & Arran MND Clinic. Interview 
transcripts will be analysed using Interpretative Phenomenological Analysis.  
Applications. This research may help to inform understanding of distress within MND and in 





Psychological distress is commonly used as an indicator and outcome of mental health, but the 
concept remains unclear as it is applied to various symptoms, behaviours and difficulties 
(Drapeau et al., 2012). Distress has been defined in a healthcare context as ‘a multi-factorial 
construct involving a complex interplay between biological, psychological, interpersonal, social 
and existential factors’ with an emphasis on taking all of these aspects of distress into account 
(Brennan et al., 2012, p. 1346). It has been proposed that the term can encompass general 
worry, fears and sadness and spiritual or existential crises as well as mental health problems 
(Holland & Bultz, 2007). Measurement of distress has been recognised as important across 
different clinical populations and health care settings due to the negative impact it can having 
on treatment seeking and quality of life (Ransom et al., 2006; Donovan et al., 2014).  
The Distress Thermometer (DT; Roth et al., 1998) and accompanying Concerns Checklist (CC) 
are tools which have been shown to be useful for screening distress and supporting health 
conversations across a range of health conditions in clinical practice (Snowden et al., 2011). 
The DT is a visual screening tool where individuals are asked to rate their level of distress over 
the past week on a scale from 0-10, with 0 indicating no distress and 10 indicating extreme 
distress. Alongside this, the CC allows patients to indicate the source(s) of their distress under 
various categories such as physical, practical and relationship problems. Brennan et al. (2012) 
have highlighted the importance of using the DT and CC as part of a structured, collaborative 
discussion in order to effectively identify and reduce distress in patients. Many studies attempt 
to establish the validity of the DT by comparing the DT to other screening measures. For 
example, various studies have established the validity of the DT as a tool to detect distress in 
cancer patients using this approach (e.g., Ma et al., 2014; Gessler et al., 2007). Evidence is 
more mixed for other health conditions and settings. Stewart-Knight et al. (2012) conducted a 
systematic review which found little evidence to support the validity of the DT across palliative 
care settings. However, they emphasised the importance of conducting qualitative interviews in 
order to understand experiences of distress, what factors contribute to distress and how this is 
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reflected in the DT. The current study aims to understand whether people with MND feel that 
the DT and CC are useful in supporting health conversations and allowing them to identify their 
main concerns.  
Health care conversations contribute to quality of patient care (Hemsley et al., 2015). It is 
particularly important to ensure that communication is effective when people experience 
communication difficulties as these individuals often do not receive support that they require to 
manage their difficulties (Wylie et al., 2013). One study found that both clients and 
professionals found preparation and structure helpful in reaching a shared understanding, which 
tools such as the DT and CC may assist with (Stans et al., 2018).  
Motor Neurone Disease (MND) covers a group of neurodegenerative diseases which primarily 
involve the progressive deterioration of motor Neurones, which control voluntary muscle 
movement e.g., movement, speech, breathing and swallowing (Young et al., 2019). These 
impairments often lead to increased dependency, changes to lifestyle and relationships (Trail et 
al., 2009). Neuropsychological deficits affect over 50% of people with MND, and these can 
vary considerably. Both cognitive and behavioural impairments are negatively and significantly 
associated with disease stage (Crockford et al., 2018). Revised criteria for frontotemporal 
dysfunction MND have been expanded to incorporate the concept of a frontotemporal spectrum 
disorder to more accurately reflect changes in executive function, language, memory and 
behaviour which can occur in MND (Strong et al., 2017). Little is known about distress related 
to these changes as many studies focusing on wellbeing have excluded participants with 
cognitive or behavioural changes; however, behavioural changes have been linked to 
hopelessness in patients and to increased caregiver burden (Caga et al., 2019). 
People with MND experience a wide range of psychological reactions, such as anxiety, 
hopelessness and distress (Averill et al., 2007). Depression and psychological distress have 
been found to be unrelated to disease progression or time since diagnosis (Rabkin et al., 2005). 
However, when psychological distress is present, it lowers quality of life (Johnston et al., 
1999), which appears to be unrelated to functional impairment (Gibbons et al., 2013). 
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Psychological distress can also reduce survival rates and increase interest in hastened death 
(McDonald et al., 1994; Ganzini et al., 2002). 
The experience of psychological distress in people with MND remains poorly understood. 
Research on the Distress Thermometer and Concerns Checklist has focused mainly on 
validating these against standardised diagnostic tools in various health conditions. However, 
measures examining distress often fail to address patients’ holistic needs, instead focusing on 
depression and anxiety. It is important that distress is continually monitored in MND, as 
patients and their families face challenges in coping with uncertainty around the nature of 
changes on a daily basis. Needs change quickly with existing symptoms progressing as new 
ones develop, as patients continuously have to adapt to a decline in their abilities, an increase in 
their dependence on others and changes across all domains of their lives (Sakellariou et al., 
2013). Bulbar symptoms lead to impairment of speech and affect up to 30% of people with 
ALS (Havervamp et al., 1995). The rate of speech impairment is difficult to predict and 
communication difficulties can be exacerbated by a loss of motor function. Communication 
difficulties change over time and have a significant impact on quality of life; it has been 
identified by MND patients as a key factor in maintaining or losing their independence (Gruis 
et al., 2011; Green et al., 2013). 
The Motor Neurone Disease Clinic (MNDC) in NHS Ayrshire and Arran (NHS A&A) 
developed and introduced the DT with an adapted Concerns Checklist (MND CC) in 2017 to be 
administered routinely at clinic appointments. This tool allows patients to address physical, 
cognitive, emotional, practical and social needs as part of their care plan alongside clinicians, 
and ensures that clinicians enquire about distress. However, there are additional challenges to 
identifying psychological and emotional needs in the MND population due to communication 
difficulties and cognitive impairment, and its clinical utility has not yet been established. MND 
services who have audited the use of adapted versions of the DT and CC have found that these 
tools have allowed patients to identify unmet needs and prompted further referrals (Wright et 
al.,, 2011) and that these were acceptable to both patients and clinical staff (Lennox et al., 
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2018). However, it is worth noting that if there are no consequences of screening (e.g., lack of 
referral for an identified need), this may increase individual distress. A systematic review found 
that when screening identified distress in cancer patients and this was associated with a lack of 
follow up care, studies reported no benefit of screening, in contrast with studies which 
demonstrated improved patient outcomes when screening was linked with mandatory referral or 
intervention (Mitchell, 2013).  
Aims  
Research has suggested that individuals with MND are at risk of experiencing distress, in 
common with many other conditions. The Distress Thermometer and Concerns Checklist have 
been implemented within the NHS A&A MNDC to help identify signs and causes of distress, 
discuss these with clients and determine an appropriate intervention if necessary. However, 
views of individuals using this have not been fully explored. The proposed study aims to better 
understand the lived experience of, and the meanings associated with, distress in the context of 
MND. Interpretative Phenomenological Analysis (IPA) will be used to provide rich and 
detailed accounts of i) participant experiences of distress within the context of a diagnosis of 
MND, if any; ii) the meaning of distress for individuals with MND; iii) participant’s views of 
using the Distress Thermometer and Concerns Checklist specifically in relation to their own 
experiences.  
Plan of Investigation 
Participants 
Patients with MND will be recruited from the NHSA&A MNDC. All patients are given the 
adapted Distress Thermometer and Concerns Checklist at every clinic 15 minutes prior to their 
appointment and use this to help guide health conversations with professionals within the clinic. 
Clinics are not currently running routinely due to government restrictions on social distancing 
due to Covid-19. For those who have experience of using the DT/CC prior to these changes, 
their views of using the tools in relation to their own experiences will be explored. All 
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participants will be sent out the tools along with participant information sheets prior to 
interviews. To what extent the DT and CC capture the experience of distress for participants 
will be explored.  
Up to 6-8 participants will be recruited for this study.  
Inclusion Criteria 
Inclusion criteria: Diagnosis of Motor Neurone Disease; registered and seen within the Motor 
Neurone Disease Clinic; cognitive capacity to communicate informed consent; aged 18 years or 
older, ability to verbally communicate. Exclusion criteria: inability to communicate consent or 
lack of cognitive capacity to give consent as identified by the clinical team; communication 
difficulties which would be considered too difficult to understand via audio recording.  
 
Recruitment Procedures 
The researcher will provide information to MNDC staff about the study, its eligibility criteria 
and recruitment procedures in order to identify potential participants. The researcher will 
prepare a participant information sheet and opt-in form. Interested participants will be invited to 
send the opt-in form via post to the researcher or to complete this with a MNDC clinician to be 
passed onto the researcher. The researcher will then contact participants by telephone to arrange 
a time for interview at the participant’s convenience and to allow an opportunity for further 
questions. Participants will be sent an outline of the project and interview process along with 
copies of the DT and CC. Concurrent data analysis will help to inform the recruitment process.  
Interview 
Semi-structured interviews will be conducted on an individual basis. Although interviews will 
be expected to last between approximately 1-1.5 hours, the researcher will be flexible with 
timings and number of interviews conducted. Participants will be given the option of multiple 
shorter interviews, and longer interviews will be conducted if required. In all cases, breaks will 
be taken as and when needed. Interviews will be recorded using digital recording equipment. 
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Field notes will also be taken by the researcher to supplement data. An interview schedule 
containing between 6 and 10 questions will be developed by the researcher, along with the 
study supervisor and MNDC staff. The interview schedule will also incorporate potential 
prompts to use during the interview process. Interpretative Phenomenological Analysis (IPA) 
aims to explore participants’ experiences, understandings, perceptions and views, and assumes 
that participants seek to interpret their experiences into a form which is understandable to them.  
 
Design 
The design of the study will be a retrospective qualitative design with data being analysed using 
IPA. One to one interviews will be carried out with participants, and these interviews will then 
be transcribed and the content explored to identify recurring themes. This method of analysis 
will be used as IPA is concerned with how people make sense of their experiences and the 
process of the researcher making sense of this process in turn. This method will allow the 
research questions relating to people with MND’s experiences of distress to be addressed 
appropriately.  
Additionally, IPA places emphasis on researcher reflexivity, acknowledging that interpretations 
of data are tied to the researcher’s ability to reflect and analyse. This is particularly important in 
this study as the researcher has no personal experience of MND, therefore engaging in 
reflective practice will allow the researcher to reduce the impact of preconceptions on 
interpretations.  
Research Procedure 
Interviews will be conducted by the researcher. Participants will be given three options of 
interview settings – in their home setting, via video conferencing software or at the MNDC - 
dependent on personal preference and government restrictions. Before commencing each 
interview, a brief outline of the research project and interview process will be given/sent to and 
read through with each participant. The DT and CC will be sent out prior to interview. The 
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researcher will go over this with participants at the end of the interview and explore whether 
this tool has captured their experiences of distress or not. Confidentiality will be explained to 
each participant, including that identifying information will be removed and that pseudonyms 
will be used during the transcription of interviews and analysis. Permission will be sought for 
recording of the interview, and storage procedures will be explained. Participants will be 
reminded that their participation is voluntary and that they are free to withdraw at any time. 
Interviews will then be transcribed by the researcher and references to persons and places will 
be anonymised. Data analysis will commence concurrently with recruitment and data 
collection, which will help to inform when recruitment should be ceased (i.e., if saturation point 
is reached after fewer interviews). All interviews will be transcribed and checked by the 
researcher.  
Data Analysis 
Data will be analysed using Interpretative Phenomenological Analysis (IPA). Smith, Flowers 
and Larkin (2009) have set out the following 6 stages for analysis: (i) Reading and re-reading 
(ii) Initial noting (iii) Developing emergent themes (iv) Searching for connections across 
emergent themes (v) Moving to the next case (vi) Looking for patterns across cases. These 
steps will be followed when analysing data in this study.  
Justification of Sample Size 
The method of IPA is typically based on, and is best suited to, small sample sizes involving 
individual interviews of participants. . In IPA research purposive sampling is normally used in 
order to have a homogenous sample. This approach will be used as much as possible but will be 
dependent on respondent rates and by the small population of people with MND. For doctoral 
level research projects, the recommended sample size is 6-8 participants (Turpin et al., 1997). 
Therefore, the study will seek a sample size of up to 6-8 participants, although this number will 
be informed by concurrent data collection in terms of when the point of saturation is reached 
with regards to richness of themes and topics explored.  
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Settings and Equipment 
Participants will be given three options of interview setting depending on preferences and 
government restrictions: 1) the MNDC, where interviews will be conducted face to face and 
recorded with an audio recorder. In this instance, interviews will be conducted within office 
hours (9-5) in a clinic room. Interviews will be conducted at times when other clinicians are 
within the clinic space and notified that interviews are taking place. 2) participant’s homes. In 
this setting, Lone Working policies for both NHS A&A and the University of Glasgow will be 
followed, and the researcher will keep these interviews within MNDC clinic hours. 3) NHS 
A&A approved video conferencing software such as Attend Anywhere. This option may be 
more convenient for participants and may be necessary as part of government response to 
Covid-19. Software such as Skype has been used in previous studies utilising this method (e.g., 
Ferolino et al., 2020) and is suggested as the most feasible alternative to interviews conducted 
face to face (Hanna, 2012). In this instance, NHS A&A guidelines regarding remote 
appointments will be followed by the researcher. Participants will be able to access a waiting 
room via a link which will be sent by letter or email after confirming the time of the interview 
that suits the participant.  
In all settings, participants will have the opportunity to reflect on how they are feeling at the 
end of the interview and to contact a psychologist or nurse from the MNDC. Participant 
information sheets, consent forms, copies of the DT/CC and stamped addressed envelopes will 
be required for participant recruitment. If participants are unable to sign a consent form due to 
limb weakness, they will be invited to give verbal consent in the presence of a witness (e.g., 
caregiver or MNDC staff member) and the researcher will record this in writing and using a 
voice recorder. 
 Interviews will be conducted on a one-to-one basis and will be audio-taped using a voice 
recorder. Recordings will be transferred to and stored on a University of Glasgow encrypted 
laptop, with recordings being deleted from the recording device. Transcriptions will be 
anonymised and stored on the laptop. Back up copies of both recordings and transcripts will be 
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stored within the Glasgow University Network, in a password protected folder only accessible 
to the researcher and supervisor. When the study is completed, recordings will be deleted from 
the university network. Transcripts will be retained on enlighten for a period of 10 years in 
keeping with policy at the University of Glasgow and will be deleted after this period. 
Health and Safety Issues 
Researcher Safety Issues 
Where possible, interviews will take place within normal working hours in MNDC office and 
will comply with standard safety procedures. MNDC staff will be aware of when interviews are 
being conducted and will be available if required. Home visits will be conducted as necessary 
and both the Lone Working Policy provided by NHS A&A and the Lone Study Procedure 
provided by the University of Glasgow will be followed. 
Participant Safety Issues 
Written or verbal consent will be obtained from the participant and the participant information 
sheet will detail information on the opportunity to opt-out at any time. The researcher will 
explain to participants that they can stop the interview or take a break at any time and will 
regularly check in with clients to check for fatigue or distress. If participants disclose risk of 
harm to self or others, the researcher will act appropriately while respecting limits of 
confidentiality.  
Ethical Issues 
All information gathered during participant interviews will remain confidential and will be 
stored in a locked filing cabinet within NHS A&A, and will be transferred to a locked filing 
cabinet within the University of Glasgow upon study completion. An NHS Research Ethics 
Committee and the Research and Development Department in NHS A&A will be contacted for 
approval of the proposed research.  
Due to the nature of the topic, it is expected that participants may become upset or distressed 
during or following interviews. During interviews, the researcher will frequently check in with 
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participants to check for fatigue or distress and ensure they are happy to continue. The 
researcher will allow time at the end of interviews for participants to reflect on how they are 
feeling. All participants will have the opportunity to contact a nurse or psychologist from the 
MNDC for support after their interview and relevant clinicians will be aware of when 
interviews are taking place.  
Financial Issues 
Funding will be required for printing up to 20 participant information sheets, up to 10 consent 
forms, up to 10 copies of the DT/CC and up to 20 stamped addressed envelopes for interested 
participants. A digital voice recorder and transcribing kit will be borrowed from the University 
of Glasgow.  
Timetable   
Submit draft proposal: January 2020 
Application to ethics and R&D: May 2020 
Recruitment commencement: October 2020 
Data analysis: October 2020-May 2021 (concurrently with recruitment) 
Writing-up: June-July 2021 
Practical Applications 
The results of the proposed research will be written up as part of a Clinical Psychology doctoral 
thesis and will be published on the Glasgow University thesis website. The research will be 
shared with interested participants, MNDC staff and submitted for publication. It may inform 
understanding of distress within MND and in turn how this is assessed and incorporated into 
treatment plans. The current research would help to provide insight into how the adapted DT 
and CC are experienced by people with MND in relation to their own experiences of distress.  
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Ideally the current study would seek to include the experiences of people who have significant 
communication difficulties, particularly given the additional distress that these impairments are 
known to bring. However, this is out with the scope of this research and would require ethical 
considerations with regards to putting people with significant communication difficulties 
through the process of taking part in lengthy interviews. Further research should seek to better 
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